[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$f5h-iJ9_Jjj434bbXfEHwSelbeamPnq8K_dNRuenb5dw":3},{"sponsor":4,"sponsorVariants":5,"totalTrials":6,"truncated":7,"activeTrials":8,"phase3Count":9,"totalEnrollment":10,"activePrograms":11,"nonDrugCount":12,"topConditions":13,"upcomingReadouts":34,"phaseBuckets":85,"rows":92},"Odense University Hospital",[4],461,false,107,20,343946,37,356,[14,17,20,23,25,27,30,32],{"name":15,"count":16},"Quality of Life",12,{"name":18,"count":19},"Type 2 Diabetes",10,{"name":21,"count":22},"Pain",9,{"name":24,"count":22},"Polycystic Ovary Syndrome",{"name":26,"count":22},"Coronary Artery Disease",{"name":28,"count":29},"Diabetes Mellitus",8,{"name":31,"count":29},"Lymphedema",{"name":33,"count":29},"Ulcerative Colitis",[35,40,45,50,55,60,65,70,75,80],{"nctId":36,"briefTitle":37,"date":38,"intervention":39},"NCT06923709","Beneficial Effect of Amiloride on Progression of Chronic Kidney Disease","2025-08-01","amiloride",{"nctId":41,"briefTitle":42,"date":43,"intervention":44},"NCT06794593","Effect Camostat for Kidney Protection in Chronic Kidney Disease","2025-12-31","Camostat Mesylate",{"nctId":46,"briefTitle":47,"date":48,"intervention":49},"NCT06050577","The Effect of Oral Semaglutide on Bone Turnover in Patients With T2D: a Randomized Placebo-controlled Clinical Trial","2026-01-15","oral Semaglutide\u002FRybelsus",{"nctId":51,"briefTitle":52,"date":53,"intervention":54},"NCT06789900","Everolimus and\u002For Exercise to Prevent Bone Loss in Postmenopausal Women","2026-03-01","Everolimus",{"nctId":56,"briefTitle":57,"date":58,"intervention":59},"NCT06421597","Identifying Individuals at Risk of Glucocorticoid-Induced Impairment of Bone Disease","2026-03-30","Prednisolone",{"nctId":61,"briefTitle":62,"date":63,"intervention":64},"NCT06306274","Topical Tacrolimus for Breast Cancer-related Lymphedema","2026-03-31","Tacrolimus",{"nctId":66,"briefTitle":67,"date":68,"intervention":69},"NCT06933355","Acute Effects of SGLT2 Inhibitor on Kidney Allograft Oxygen Tension","2026-04-01","JARDIANCE 25mg",{"nctId":71,"briefTitle":72,"date":73,"intervention":74},"NCT06018467","Senolytics to Improve Osteoporosis Therapy","2026-04-30","Dasatinib 100 Mg Oral",{"nctId":76,"briefTitle":77,"date":78,"intervention":79},"NCT04846803","Bacterial Interference for Preventing Recurrent Urinary Tract Infection - New Ways of Treatment","2026-08-01","ABU bladder lavage",{"nctId":81,"briefTitle":82,"date":83,"intervention":84},"NCT05947669","Efficacy and Safety of Infliximab for Immune Checkpoint Inhibitor Induced Colitis","2026-09","Infliximab",[86,87,88,89,90,91],"EARLY_PHASE1","PHASE1","PHASE2","PHASE3","PHASE4","NA",[93,126,153,171,193,220,246,273,299,326,344,362,394,431,449,467,499,525,559,608,630,648,675,693,720,741,763,784,814,832,856,882,904,922,948,975,993,1017,1054,1091,1130,1164,1202,1227,1250,1275,1298,1325,1343,1366,1392,1417,1442,1497,1520,1544,1562,1584,1602,1620,1638,1656,1674,1698,1716,1738,1764,1795,1813,1831,1849,1867,1890,1908,1931,1949,1967,1985,2011,2029,2047,2070,2094,2119,2145,2170,2193,2220,2245,2270,2298,2316,2343,2369,2392,2410,2428,2453,2479,2503,2526,2551,2578,2596,2625,2651,2692,2733,2767,2789,2815,2839,2864,2891,2917,2942,2960,2983,3008,3033,3051,3069,3094,3119,3145,3163,3181,3203,3221,3244],{"intervention":94,"totalTrials":95,"cells":96},"SGLT-2 inhibitor",1,{"EARLY_PHASE1":97,"PHASE1":100,"PHASE2":102,"PHASE3":104,"PHASE4":106,"NA":124},{"trials":98,"activeCount":99},[],0,{"trials":101,"activeCount":99},[],{"trials":103,"activeCount":99},[],{"trials":105,"activeCount":99},[],{"trials":107,"activeCount":95,"soonestReadout":113},[108],{"nctId":109,"briefTitle":110,"status":111,"phases":112,"primaryCompletion":113,"completion":114,"start":115,"enrollment":116,"conditions":117,"interventions":123},"NCT07143773","SGLT2i Safety and Efficacy on Kidney Allograft Function in Non-diabetic Kidney Transplant Recipients","RECRUITING",[90],"2027-06-01","2027-08-01","2025-09-01",88,[118,119,120,121,122],"Kidney Transplantation Recipients","Sodium-Glucose Transporter 2 Inhibitors","Non-Diabetic Patients","Randomized Controlled Trial","Placebo Control Design",[94],{"trials":125,"activeCount":99},[],{"intervention":127,"totalTrials":95,"cells":128},"Short duration of aspirin and prasugrel",{"EARLY_PHASE1":129,"PHASE1":131,"PHASE2":133,"PHASE3":135,"PHASE4":137,"NA":151},{"trials":130,"activeCount":99},[],{"trials":132,"activeCount":99},[],{"trials":134,"activeCount":99},[],{"trials":136,"activeCount":99},[],{"trials":138,"activeCount":95,"soonestReadout":143},[139],{"nctId":140,"briefTitle":141,"status":111,"phases":142,"primaryCompletion":143,"completion":144,"start":145,"enrollment":146,"conditions":147,"interventions":149},"NCT06718179","Comparison of Short Versus 12 Months Prasugrel Plus Aspirin in Patients with Acute Coronary Syndromes Treated with Percutaneous Coronary Intervention and Everolimus-eluting Stents",[90],"2029-11","2030-12","2024-11-16",3150,[148],"Acute Coronary Syndrome",[127,150],"Conventional duration of aspirin and prasugrel",{"trials":152,"activeCount":99},[],{"intervention":150,"totalTrials":95,"cells":154},{"EARLY_PHASE1":155,"PHASE1":157,"PHASE2":159,"PHASE3":161,"PHASE4":163,"NA":169},{"trials":156,"activeCount":99},[],{"trials":158,"activeCount":99},[],{"trials":160,"activeCount":99},[],{"trials":162,"activeCount":99},[],{"trials":164,"activeCount":95,"soonestReadout":143},[165],{"nctId":140,"briefTitle":141,"status":111,"phases":166,"primaryCompletion":143,"completion":144,"start":145,"enrollment":146,"conditions":167,"interventions":168},[90],[148],[127,150],{"trials":170,"activeCount":99},[],{"intervention":69,"totalTrials":95,"cells":172},{"EARLY_PHASE1":173,"PHASE1":175,"PHASE2":177,"PHASE3":179,"PHASE4":181,"NA":191},{"trials":174,"activeCount":99},[],{"trials":176,"activeCount":99},[],{"trials":178,"activeCount":99},[],{"trials":180,"activeCount":99},[],{"trials":182,"activeCount":95,"soonestReadout":68},[183],{"nctId":66,"briefTitle":67,"status":184,"phases":185,"primaryCompletion":68,"completion":186,"start":187,"enrollment":29,"conditions":188,"interventions":190},"ACTIVE_NOT_RECRUITING",[90],"2026-06-01","2025-03-27",[118,189,119,120,121,122],"Magnetic Resonance Imaging (MRI)",[69],{"trials":192,"activeCount":99},[],{"intervention":194,"totalTrials":95,"cells":195},"OAC will be discontinued for the duration of the trial",{"EARLY_PHASE1":196,"PHASE1":198,"PHASE2":200,"PHASE3":202,"PHASE4":204,"NA":218},{"trials":197,"activeCount":99},[],{"trials":199,"activeCount":99},[],{"trials":201,"activeCount":99},[],{"trials":203,"activeCount":99},[],{"trials":205,"activeCount":95,"soonestReadout":210},[206],{"nctId":207,"briefTitle":208,"status":111,"phases":209,"primaryCompletion":210,"completion":210,"start":211,"enrollment":212,"conditions":213,"interventions":217},"NCT06401616","Can Patients With Atrial Fibrillation Safely Discontinue Anticoagulant Therapy After Cardiac Surgery? (ATLAAC)",[90],"2028-03","2024-05-21",1220,[214,215,216],"Atrial Fibrillation","Left Atrial Appendage Absent","Anticoagulant Adverse Reaction",[194],{"trials":219,"activeCount":99},[],{"intervention":221,"totalTrials":95,"cells":222},"Alendronate 70mg weekly",{"EARLY_PHASE1":223,"PHASE1":225,"PHASE2":227,"PHASE3":229,"PHASE4":231,"NA":244},{"trials":224,"activeCount":99},[],{"trials":226,"activeCount":99},[],{"trials":228,"activeCount":99},[],{"trials":230,"activeCount":99},[],{"trials":232,"activeCount":95,"soonestReadout":237},[233],{"nctId":234,"briefTitle":235,"status":111,"phases":236,"primaryCompletion":237,"completion":238,"start":239,"enrollment":240,"conditions":241,"interventions":243},"NCT06864130","A Clinical Study on the Effect of Discontinuing Alendronate in Postmenopausal Women With Osteoporosis After a Treatment Period Without Fractures",[90],"2029-03-01","2029-09-15","2025-02-21",1400,[242],"Osteoporosis in Post-menopausal Women",[221],{"trials":245,"activeCount":99},[],{"intervention":247,"totalTrials":95,"cells":248},"PK-model to decide when to dose Vedolizumab and Ustekinumab",{"EARLY_PHASE1":249,"PHASE1":251,"PHASE2":253,"PHASE3":255,"PHASE4":257,"NA":271},{"trials":250,"activeCount":99},[],{"trials":252,"activeCount":99},[],{"trials":254,"activeCount":99},[],{"trials":256,"activeCount":99},[],{"trials":258,"activeCount":95,"soonestReadout":264},[259],{"nctId":260,"briefTitle":261,"status":262,"phases":263,"primaryCompletion":264,"completion":265,"start":115,"enrollment":266,"conditions":267,"interventions":270},"NCT06788340","MOdel-Informed Precision Dosing of Ustekinumab and VEdolizumab in Inflammatory Bowel Disease","NOT_YET_RECRUITING",[90],"2027-08-30","2027-11-01",166,[268,269,33],"Inflammatory Bowel Diseases","Crohn Disease",[247],{"trials":272,"activeCount":99},[],{"intervention":274,"totalTrials":95,"cells":275},"Protein pump inhibitor.",{"EARLY_PHASE1":276,"PHASE1":278,"PHASE2":280,"PHASE3":282,"PHASE4":284,"NA":297},{"trials":277,"activeCount":99},[],{"trials":279,"activeCount":99},[],{"trials":281,"activeCount":99},[],{"trials":283,"activeCount":99},[],{"trials":285,"activeCount":95,"soonestReadout":290},[286],{"nctId":287,"briefTitle":288,"status":111,"phases":289,"primaryCompletion":290,"completion":290,"start":291,"enrollment":292,"conditions":293,"interventions":296},"NCT06255886","Treatment of Gastroesophageal Reflux Disease in Infants",[90],"2026-12-26","2025-10-27",96,[294,295],"Gastroesophageal Reflux","Infant, Newborn, Diseases",[274],{"trials":298,"activeCount":99},[],{"intervention":300,"totalTrials":95,"cells":301},"Bisacodyl",{"EARLY_PHASE1":302,"PHASE1":304,"PHASE2":306,"PHASE3":308,"PHASE4":310,"NA":324},{"trials":303,"activeCount":99},[],{"trials":305,"activeCount":99},[],{"trials":307,"activeCount":99},[],{"trials":309,"activeCount":99},[],{"trials":311,"activeCount":95,"soonestReadout":316},[312],{"nctId":313,"briefTitle":314,"status":111,"phases":315,"primaryCompletion":316,"completion":316,"start":317,"enrollment":318,"conditions":319,"interventions":321},"NCT06455813","What Laxative Should be Used After Hip Fracture Surgery?",[90],"2027-01-31","2024-10-07",375,[320],"Hip Fractures",[300,322,323],"Macrogol 3350 and electrolytes","A combination of macrogol 3350 and electrolytes and bisacodyl",{"trials":325,"activeCount":99},[],{"intervention":322,"totalTrials":95,"cells":327},{"EARLY_PHASE1":328,"PHASE1":330,"PHASE2":332,"PHASE3":334,"PHASE4":336,"NA":342},{"trials":329,"activeCount":99},[],{"trials":331,"activeCount":99},[],{"trials":333,"activeCount":99},[],{"trials":335,"activeCount":99},[],{"trials":337,"activeCount":95,"soonestReadout":316},[338],{"nctId":313,"briefTitle":314,"status":111,"phases":339,"primaryCompletion":316,"completion":316,"start":317,"enrollment":318,"conditions":340,"interventions":341},[90],[320],[300,322,323],{"trials":343,"activeCount":99},[],{"intervention":323,"totalTrials":95,"cells":345},{"EARLY_PHASE1":346,"PHASE1":348,"PHASE2":350,"PHASE3":352,"PHASE4":354,"NA":360},{"trials":347,"activeCount":99},[],{"trials":349,"activeCount":99},[],{"trials":351,"activeCount":99},[],{"trials":353,"activeCount":99},[],{"trials":355,"activeCount":95,"soonestReadout":316},[356],{"nctId":313,"briefTitle":314,"status":111,"phases":357,"primaryCompletion":316,"completion":316,"start":317,"enrollment":318,"conditions":358,"interventions":359},[90],[320],[300,322,323],{"trials":361,"activeCount":99},[],{"intervention":59,"totalTrials":363,"cells":364},2,{"EARLY_PHASE1":365,"PHASE1":367,"PHASE2":369,"PHASE3":379,"PHASE4":390,"NA":392},{"trials":366,"activeCount":99},[],{"trials":368,"activeCount":99},[],{"trials":370,"activeCount":95,"soonestReadout":58},[371],{"nctId":56,"briefTitle":57,"status":184,"phases":372,"primaryCompletion":58,"completion":373,"start":374,"enrollment":375,"conditions":376,"interventions":378},[88],"2026-04","2024-11-04",36,[377],"Osteoporosis Secondary",[59],{"trials":380,"activeCount":95,"soonestReadout":83},[381],{"nctId":81,"briefTitle":82,"status":111,"phases":382,"primaryCompletion":83,"completion":383,"start":384,"enrollment":385,"conditions":386,"interventions":388},[89],"2028-09","2023-08-22",195,[387],"Colitis",[84,389,59],"Methylprednisolone",{"trials":391,"activeCount":99},[],{"trials":393,"activeCount":99},[],{"intervention":64,"totalTrials":363,"cells":395},{"EARLY_PHASE1":396,"PHASE1":398,"PHASE2":400,"PHASE3":402,"PHASE4":411,"NA":429},{"trials":397,"activeCount":99},[],{"trials":399,"activeCount":99},[],{"trials":401,"activeCount":99},[],{"trials":403,"activeCount":95,"soonestReadout":63},[404],{"nctId":61,"briefTitle":62,"status":405,"phases":406,"primaryCompletion":63,"completion":63,"start":407,"enrollment":408,"conditions":409,"interventions":410},"ENROLLING_BY_INVITATION",[88,89],"2024-09-09",80,[31],[64],{"trials":412,"activeCount":99},[413],{"nctId":414,"briefTitle":415,"status":416,"phases":417,"primaryCompletion":418,"completion":418,"start":419,"enrollment":375,"conditions":420,"interventions":423},"NCT00779792","Efficacy of Glycerol, Two Topical Steroids, and a Topical Immune Modulator Against Skin Irritation","UNKNOWN",[90],"2008-11","2008-09",[421,422],"Dermatitis, Contact","Dermatitis, Occupational",[424,425,426,427,428],"clobetasol","triamcinolone acetonide","tacrolimus","glycerol","vehicle ointment",{"trials":430,"activeCount":99},[],{"intervention":84,"totalTrials":95,"cells":432},{"EARLY_PHASE1":433,"PHASE1":435,"PHASE2":437,"PHASE3":439,"PHASE4":445,"NA":447},{"trials":434,"activeCount":99},[],{"trials":436,"activeCount":99},[],{"trials":438,"activeCount":99},[],{"trials":440,"activeCount":95,"soonestReadout":83},[441],{"nctId":81,"briefTitle":82,"status":111,"phases":442,"primaryCompletion":83,"completion":383,"start":384,"enrollment":385,"conditions":443,"interventions":444},[89],[387],[84,389,59],{"trials":446,"activeCount":99},[],{"trials":448,"activeCount":99},[],{"intervention":389,"totalTrials":95,"cells":450},{"EARLY_PHASE1":451,"PHASE1":453,"PHASE2":455,"PHASE3":457,"PHASE4":463,"NA":465},{"trials":452,"activeCount":99},[],{"trials":454,"activeCount":99},[],{"trials":456,"activeCount":99},[],{"trials":458,"activeCount":95,"soonestReadout":83},[459],{"nctId":81,"briefTitle":82,"status":111,"phases":460,"primaryCompletion":83,"completion":383,"start":384,"enrollment":385,"conditions":461,"interventions":462},[89],[387],[84,389,59],{"trials":464,"activeCount":99},[],{"trials":466,"activeCount":99},[],{"intervention":468,"totalTrials":95,"cells":469},"Noradrenaline",{"EARLY_PHASE1":470,"PHASE1":472,"PHASE2":474,"PHASE3":476,"PHASE4":495,"NA":497},{"trials":471,"activeCount":99},[],{"trials":473,"activeCount":99},[],{"trials":475,"activeCount":99},[],{"trials":477,"activeCount":95,"soonestReadout":482},[478],{"nctId":479,"briefTitle":480,"status":111,"phases":481,"primaryCompletion":482,"completion":316,"start":483,"enrollment":484,"conditions":485,"interventions":494},"NCT05931601","Early Initiated Vasopressor Therapy in the Emergency Department",[89],"2026-12-31","2023-12-08",320,[486,487,488,489,490,491,492,493],"Shock","Shock, Septic","Hypotension","Hypotension and Shock","Hypotension Symptomatic","Hypovolemia","Hypovolemic Shock","Hypovolemic",[468],{"trials":496,"activeCount":99},[],{"trials":498,"activeCount":99},[],{"intervention":500,"totalTrials":95,"cells":501},"Methylphenidate",{"EARLY_PHASE1":502,"PHASE1":504,"PHASE2":506,"PHASE3":508,"PHASE4":521,"NA":523},{"trials":503,"activeCount":99},[],{"trials":505,"activeCount":99},[],{"trials":507,"activeCount":99},[],{"trials":509,"activeCount":95,"soonestReadout":514},[510],{"nctId":511,"briefTitle":512,"status":111,"phases":513,"primaryCompletion":514,"completion":514,"start":515,"enrollment":516,"conditions":517,"interventions":520},"NCT06905587","Methylphenidate in Pediatric Brain Tumor Survivors With Cancer-related Fatigue",[89],"2029-12","2025-09-02",50,[518,519,500],"Brain Tumor, Pediatric","Cancer-related Fatigue",[500],{"trials":522,"activeCount":99},[],{"trials":524,"activeCount":99},[],{"intervention":54,"totalTrials":363,"cells":526},{"EARLY_PHASE1":527,"PHASE1":529,"PHASE2":531,"PHASE3":553,"PHASE4":555,"NA":557},{"trials":528,"activeCount":99},[],{"trials":530,"activeCount":99},[],{"trials":532,"activeCount":363,"soonestReadout":53},[533,545],{"nctId":534,"briefTitle":535,"status":111,"phases":536,"primaryCompletion":537,"completion":537,"start":538,"enrollment":539,"conditions":540,"interventions":544},"NCT07191353","Resistance Training and Rapamycin to Enhance Bone Formation in Postmenopausal Women",[88],"2027-03-01","2025-10-20",148,[541,542,543],"Healthy","Osteopenia","Osteoporosis Risk",[54],{"nctId":51,"briefTitle":52,"status":184,"phases":546,"primaryCompletion":53,"completion":547,"start":548,"enrollment":549,"conditions":550,"interventions":552},[88],"2026-10-01","2024-10-14",136,[551],"Postmenopausal Women",[54],{"trials":554,"activeCount":99},[],{"trials":556,"activeCount":99},[],{"trials":558,"activeCount":99},[],{"intervention":560,"totalTrials":561,"cells":562},"Saline",3,{"EARLY_PHASE1":563,"PHASE1":565,"PHASE2":567,"PHASE3":579,"PHASE4":581,"NA":606},{"trials":564,"activeCount":99},[],{"trials":566,"activeCount":99},[],{"trials":568,"activeCount":95,"soonestReadout":573},[569],{"nctId":570,"briefTitle":571,"status":262,"phases":572,"primaryCompletion":573,"completion":573,"start":574,"enrollment":16,"conditions":575,"interventions":577},"NCT07488988","SCARFREE-001: Verteporfin for Scar Prevention",[88],"2028-02","2026-06",[576],"Surgical Scar",[578,560],"Verteporfin",{"trials":580,"activeCount":99},[],{"trials":582,"activeCount":99},[583,595],{"nctId":584,"briefTitle":585,"status":586,"phases":587,"primaryCompletion":588,"completion":588,"start":589,"enrollment":590,"conditions":591,"interventions":593},"NCT01119209","Postoperative Analgesia With Local Infiltration After Hip Fracture Of Intertrochanteric Type","COMPLETED",[90],"2011-01","2008-02",74,[592],"Hip Fracture of Intertrochanteric Type",[594,560],"Ropivacaine",{"nctId":596,"briefTitle":597,"status":586,"phases":598,"primaryCompletion":599,"completion":599,"start":600,"enrollment":601,"conditions":602,"interventions":604},"NCT03044808","Investigation of the Effect of Intravenous Lidocaine Infusion on Postoperative Pain Treatment and Bowel Function in Robotic Bowel Surgery",[90],"2017-04-19","2016-02-02",60,[603],"Opioid Use",[605,560],"Lidocaine",{"trials":607,"activeCount":99},[],{"intervention":44,"totalTrials":95,"cells":609},{"EARLY_PHASE1":610,"PHASE1":612,"PHASE2":614,"PHASE3":624,"PHASE4":626,"NA":628},{"trials":611,"activeCount":99},[],{"trials":613,"activeCount":99},[],{"trials":615,"activeCount":95,"soonestReadout":43},[616],{"nctId":41,"briefTitle":42,"status":111,"phases":617,"primaryCompletion":43,"completion":618,"start":619,"enrollment":620,"conditions":621,"interventions":623},[88],"2027-02-28","2024-11-21",40,[622],"Chronic Kidney Disease(CKD)",[44],{"trials":625,"activeCount":99},[],{"trials":627,"activeCount":99},[],{"trials":629,"activeCount":99},[],{"intervention":578,"totalTrials":95,"cells":631},{"EARLY_PHASE1":632,"PHASE1":634,"PHASE2":636,"PHASE3":642,"PHASE4":644,"NA":646},{"trials":633,"activeCount":99},[],{"trials":635,"activeCount":99},[],{"trials":637,"activeCount":95,"soonestReadout":573},[638],{"nctId":570,"briefTitle":571,"status":262,"phases":639,"primaryCompletion":573,"completion":573,"start":574,"enrollment":16,"conditions":640,"interventions":641},[88],[576],[578,560],{"trials":643,"activeCount":99},[],{"trials":645,"activeCount":99},[],{"trials":647,"activeCount":99},[],{"intervention":649,"totalTrials":95,"cells":650},"Nivolumab",{"EARLY_PHASE1":651,"PHASE1":653,"PHASE2":655,"PHASE3":669,"PHASE4":671,"NA":673},{"trials":652,"activeCount":99},[],{"trials":654,"activeCount":99},[],{"trials":656,"activeCount":95,"soonestReadout":661},[657],{"nctId":658,"briefTitle":659,"status":111,"phases":660,"primaryCompletion":661,"completion":662,"start":663,"enrollment":664,"conditions":665,"interventions":667},"NCT05732389","Immunotherapy in Patients With Early dMMR Rectal Cancer",[88],"2027-07","2052-02","2023-02-01",39,[666],"Cancer of Rectum",[649,668],"Ipilimumab",{"trials":670,"activeCount":99},[],{"trials":672,"activeCount":99},[],{"trials":674,"activeCount":99},[],{"intervention":668,"totalTrials":95,"cells":676},{"EARLY_PHASE1":677,"PHASE1":679,"PHASE2":681,"PHASE3":687,"PHASE4":689,"NA":691},{"trials":678,"activeCount":99},[],{"trials":680,"activeCount":99},[],{"trials":682,"activeCount":95,"soonestReadout":661},[683],{"nctId":658,"briefTitle":659,"status":111,"phases":684,"primaryCompletion":661,"completion":662,"start":663,"enrollment":664,"conditions":685,"interventions":686},[88],[666],[649,668],{"trials":688,"activeCount":99},[],{"trials":690,"activeCount":99},[],{"trials":692,"activeCount":99},[],{"intervention":694,"totalTrials":95,"cells":695},"Faecal microbiota transplantation",{"EARLY_PHASE1":696,"PHASE1":698,"PHASE2":700,"PHASE3":714,"PHASE4":716,"NA":718},{"trials":697,"activeCount":99},[],{"trials":699,"activeCount":99},[],{"trials":701,"activeCount":95,"soonestReadout":537},[702],{"nctId":703,"briefTitle":704,"status":111,"phases":705,"primaryCompletion":537,"completion":706,"start":707,"enrollment":708,"conditions":709,"interventions":713},"NCT04924270","Safety and Efficacy of Capsule FMT in Treatment-naïve Patients With Newly Diagnosed Chronic Inflammatory Diseases",[88],"2027-12-31","2023-12-13",200,[710,711,712,269,33],"Rheumatoid Arthritis","Ankylosing Spondylitis","Psoriatic Arthritis",[694],{"trials":715,"activeCount":99},[],{"trials":717,"activeCount":99},[],{"trials":719,"activeCount":99},[],{"intervention":49,"totalTrials":95,"cells":721},{"EARLY_PHASE1":722,"PHASE1":724,"PHASE2":726,"PHASE3":735,"PHASE4":737,"NA":739},{"trials":723,"activeCount":99},[],{"trials":725,"activeCount":99},[],{"trials":727,"activeCount":95,"soonestReadout":48},[728],{"nctId":46,"briefTitle":47,"status":184,"phases":729,"primaryCompletion":48,"completion":730,"start":731,"enrollment":732,"conditions":733,"interventions":734},[88],"2027-01-15","2024-06-07",64,[18,542],[49],{"trials":736,"activeCount":99},[],{"trials":738,"activeCount":99},[],{"trials":740,"activeCount":99},[],{"intervention":74,"totalTrials":95,"cells":742},{"EARLY_PHASE1":743,"PHASE1":745,"PHASE2":747,"PHASE3":757,"PHASE4":759,"NA":761},{"trials":744,"activeCount":99},[],{"trials":746,"activeCount":99},[],{"trials":748,"activeCount":95,"soonestReadout":73},[749],{"nctId":71,"briefTitle":72,"status":184,"phases":750,"primaryCompletion":73,"completion":73,"start":751,"enrollment":752,"conditions":753,"interventions":756},[88],"2023-09-06",120,[754,755],"Osteopenia, Osteoporosis","Age-related Bone Loss",[74],{"trials":758,"activeCount":99},[],{"trials":760,"activeCount":99},[],{"trials":762,"activeCount":99},[],{"intervention":39,"totalTrials":95,"cells":764},{"EARLY_PHASE1":765,"PHASE1":767,"PHASE2":769,"PHASE3":778,"PHASE4":780,"NA":782},{"trials":766,"activeCount":99},[],{"trials":768,"activeCount":99},[],{"trials":770,"activeCount":95,"soonestReadout":38},[771],{"nctId":36,"briefTitle":37,"status":111,"phases":772,"primaryCompletion":38,"completion":773,"start":774,"enrollment":620,"conditions":775,"interventions":777},[88],"2025-11-01","2024-10-10",[622,776],"Proteinuria",[39],{"trials":779,"activeCount":99},[],{"trials":781,"activeCount":99},[],{"trials":783,"activeCount":99},[],{"intervention":785,"totalTrials":95,"cells":786},"Cisplatin",{"EARLY_PHASE1":787,"PHASE1":789,"PHASE2":791,"PHASE3":808,"PHASE4":810,"NA":812},{"trials":788,"activeCount":99},[],{"trials":790,"activeCount":99},[],{"trials":792,"activeCount":95,"soonestReadout":797},[793],{"nctId":794,"briefTitle":795,"status":262,"phases":796,"primaryCompletion":797,"completion":798,"start":799,"enrollment":800,"conditions":801,"interventions":806},"NCT06295094","The Efficacy of PIPAC and Minimally Invasive Radical Resection in High-risk Gastric Cancer Patients.",[88],"2027-01","2028-01","2024-09",264,[802,803,804,805],"Gastric Cancer","Chemotherapy, Adjuvant","Peritoneal Metastases","Minimally Invasive Surgical Procedures",[785,807],"Doxorubicin",{"trials":809,"activeCount":99},[],{"trials":811,"activeCount":99},[],{"trials":813,"activeCount":99},[],{"intervention":807,"totalTrials":95,"cells":815},{"EARLY_PHASE1":816,"PHASE1":818,"PHASE2":820,"PHASE3":826,"PHASE4":828,"NA":830},{"trials":817,"activeCount":99},[],{"trials":819,"activeCount":99},[],{"trials":821,"activeCount":95,"soonestReadout":797},[822],{"nctId":794,"briefTitle":795,"status":262,"phases":823,"primaryCompletion":797,"completion":798,"start":799,"enrollment":800,"conditions":824,"interventions":825},[88],[802,803,804,805],[785,807],{"trials":827,"activeCount":99},[],{"trials":829,"activeCount":99},[],{"trials":831,"activeCount":99},[],{"intervention":833,"totalTrials":95,"cells":834},"68Ga-FAP-2286",{"EARLY_PHASE1":835,"PHASE1":837,"PHASE2":839,"PHASE3":850,"PHASE4":852,"NA":854},{"trials":836,"activeCount":99},[],{"trials":838,"activeCount":99},[],{"trials":840,"activeCount":95,"soonestReadout":798},[841],{"nctId":842,"briefTitle":843,"status":262,"phases":844,"primaryCompletion":798,"completion":845,"start":186,"enrollment":846,"conditions":847,"interventions":849},"NCT07523607","FAP PET\u002FCT for Staging Patients With Breast Cancer",[88],"2029-01",65,[848],"Breast Cancer Detection",[833],{"trials":851,"activeCount":99},[],{"trials":853,"activeCount":99},[],{"trials":855,"activeCount":99},[],{"intervention":857,"totalTrials":95,"cells":858},"Allergen Immunotherapy Extract",{"EARLY_PHASE1":859,"PHASE1":861,"PHASE2":863,"PHASE3":865,"PHASE4":867,"NA":869},{"trials":860,"activeCount":99},[],{"trials":862,"activeCount":99},[],{"trials":864,"activeCount":99},[],{"trials":866,"activeCount":99},[],{"trials":868,"activeCount":99},[],{"trials":870,"activeCount":95,"soonestReadout":875},[871],{"nctId":872,"briefTitle":873,"status":111,"phases":874,"primaryCompletion":875,"completion":876,"start":877,"enrollment":878,"conditions":879,"interventions":881},"NCT06421415","Long Term Effect of AIT in Children",[],"2036-12-01","2037-05-01","2024-05-01",100,[880],"Allergy in Children",[857],{"intervention":79,"totalTrials":95,"cells":883},{"EARLY_PHASE1":884,"PHASE1":886,"PHASE2":888,"PHASE3":890,"PHASE4":892,"NA":894},{"trials":885,"activeCount":99},[],{"trials":887,"activeCount":99},[],{"trials":889,"activeCount":99},[],{"trials":891,"activeCount":99},[],{"trials":893,"activeCount":99},[],{"trials":895,"activeCount":95,"soonestReadout":78},[896],{"nctId":76,"briefTitle":77,"status":111,"phases":897,"primaryCompletion":78,"completion":898,"start":899,"enrollment":408,"conditions":900,"interventions":902},[91],"2027-12-01","2024-01-09",[901],"Recurrent Urinary Tract Infections",[79,903],"Saline bladder lavage",{"intervention":903,"totalTrials":95,"cells":905},{"EARLY_PHASE1":906,"PHASE1":908,"PHASE2":910,"PHASE3":912,"PHASE4":914,"NA":916},{"trials":907,"activeCount":99},[],{"trials":909,"activeCount":99},[],{"trials":911,"activeCount":99},[],{"trials":913,"activeCount":99},[],{"trials":915,"activeCount":99},[],{"trials":917,"activeCount":95,"soonestReadout":78},[918],{"nctId":76,"briefTitle":77,"status":111,"phases":919,"primaryCompletion":78,"completion":898,"start":899,"enrollment":408,"conditions":920,"interventions":921},[91],[901],[79,903],{"intervention":923,"totalTrials":95,"cells":924},"Blood samples",{"EARLY_PHASE1":925,"PHASE1":927,"PHASE2":929,"PHASE3":931,"PHASE4":933,"NA":935},{"trials":926,"activeCount":99},[],{"trials":928,"activeCount":99},[],{"trials":930,"activeCount":99},[],{"trials":932,"activeCount":99},[],{"trials":934,"activeCount":99},[],{"trials":936,"activeCount":95,"soonestReadout":941},[937],{"nctId":938,"briefTitle":939,"status":405,"phases":940,"primaryCompletion":941,"completion":941,"start":942,"enrollment":943,"conditions":944,"interventions":947},"NCT07578597","The BAMBI II Study",[91],"2028-02-01","2025-04-01",225,[945,946],"Hypo- and Hyperglycemia Following Bariatric Surgery","Association Between Glucose Excursions, Fetal Growth and Neonatal Body Composition",[923],{"intervention":949,"totalTrials":95,"cells":950},"Carvedilol",{"EARLY_PHASE1":951,"PHASE1":953,"PHASE2":955,"PHASE3":957,"PHASE4":959,"NA":961},{"trials":952,"activeCount":99},[],{"trials":954,"activeCount":99},[],{"trials":956,"activeCount":99},[],{"trials":958,"activeCount":99},[],{"trials":960,"activeCount":99},[],{"trials":962,"activeCount":95,"soonestReadout":967},[963],{"nctId":964,"briefTitle":965,"status":262,"phases":966,"primaryCompletion":967,"completion":968,"start":969,"enrollment":970,"conditions":971,"interventions":973},"NCT04996550","Are Carvedilol and Metoprolol Succinate Comparable Treatments in Heart Failure Patients With Reduced Ejection Fraction",[],"2028-01-02","2028-12-18","2022-01-03",5600,[972],"Chronic Heart Failure",[949,974],"Metoprolol Succinate",{"intervention":974,"totalTrials":95,"cells":976},{"EARLY_PHASE1":977,"PHASE1":979,"PHASE2":981,"PHASE3":983,"PHASE4":985,"NA":987},{"trials":978,"activeCount":99},[],{"trials":980,"activeCount":99},[],{"trials":982,"activeCount":99},[],{"trials":984,"activeCount":99},[],{"trials":986,"activeCount":99},[],{"trials":988,"activeCount":95,"soonestReadout":967},[989],{"nctId":964,"briefTitle":965,"status":262,"phases":990,"primaryCompletion":967,"completion":968,"start":969,"enrollment":970,"conditions":991,"interventions":992},[],[972],[949,974],{"intervention":994,"totalTrials":95,"cells":995},"Atorvastatin 80mg",{"EARLY_PHASE1":996,"PHASE1":998,"PHASE2":1000,"PHASE3":1002,"PHASE4":1004,"NA":1006},{"trials":997,"activeCount":99},[],{"trials":999,"activeCount":99},[],{"trials":1001,"activeCount":99},[],{"trials":1003,"activeCount":99},[],{"trials":1005,"activeCount":99},[],{"trials":1007,"activeCount":95,"soonestReadout":898},[1008],{"nctId":1009,"briefTitle":1010,"status":111,"phases":1011,"primaryCompletion":898,"completion":898,"start":1012,"enrollment":1013,"conditions":1014,"interventions":1016},"NCT05076019","Statin Therapy With Atorvastatin in Surgical Aortic Valve Replacement",[91],"2022-02-01",266,[1015],"Postoperative Atrial Fibrillation",[994],{"intervention":594,"totalTrials":561,"cells":1018},{"EARLY_PHASE1":1019,"PHASE1":1021,"PHASE2":1023,"PHASE3":1025,"PHASE4":1027,"NA":1052},{"trials":1020,"activeCount":99},[],{"trials":1022,"activeCount":99},[],{"trials":1024,"activeCount":99},[],{"trials":1026,"activeCount":99},[],{"trials":1028,"activeCount":99},[1029,1039,1048],{"nctId":1030,"briefTitle":1031,"status":586,"phases":1032,"primaryCompletion":1033,"completion":1033,"start":1034,"enrollment":1035,"conditions":1036,"interventions":1038},"NCT00815503","Postoperative Analgesia With Local Infiltration After Periacetabular Osteotomy",[90],"2010-12","2009-01",70,[1037,21],"Periacetabular Osteotomy",[594],{"nctId":1040,"briefTitle":1041,"status":586,"phases":1042,"completion":1043,"start":1044,"enrollment":516,"conditions":1045,"interventions":1047},"NCT00529425","Postoperative Analgesia With Local Infiltration After Femoral Neck Fracture",[90],"2008-12","2008-01",[1046],"Femoral Neck Fracture",[594],{"nctId":584,"briefTitle":585,"status":586,"phases":1049,"primaryCompletion":588,"completion":588,"start":589,"enrollment":590,"conditions":1050,"interventions":1051},[90],[592],[594,560],{"trials":1053,"activeCount":99},[],{"intervention":1055,"totalTrials":363,"cells":1056},"Methimazole",{"EARLY_PHASE1":1057,"PHASE1":1059,"PHASE2":1061,"PHASE3":1075,"PHASE4":1077,"NA":1089},{"trials":1058,"activeCount":99},[],{"trials":1060,"activeCount":99},[],{"trials":1062,"activeCount":99},[1063],{"nctId":1064,"briefTitle":1065,"status":586,"phases":1066,"completion":1067,"start":1068,"enrollment":9,"conditions":1069,"interventions":1072},"NCT00150111","Rituximab in the Treatment of Graves' Disease",[87,88],"2006-10","2003-06",[1070,1071],"Graves´ Disease","Thyroid Associated Ophthalmopathy",[1055,1073,1074],"Rituximab","Immunization with various vaccines",{"trials":1076,"activeCount":99},[],{"trials":1078,"activeCount":99},[1079],{"nctId":1080,"briefTitle":1081,"status":586,"phases":1082,"completion":1083,"start":1084,"enrollment":408,"conditions":1085,"interventions":1088},"NCT00150137","Antithyroid Drugs During Radioiodine Therapy",[90],"2004-12","2003-01",[1086,1087],"Toxic Nodular Goitre","Graves Disease",[1055],{"trials":1090,"activeCount":99},[],{"intervention":1092,"totalTrials":363,"cells":1093},"Cefuroxime",{"EARLY_PHASE1":1094,"PHASE1":1096,"PHASE2":1098,"PHASE3":1100,"PHASE4":1102,"NA":1128},{"trials":1095,"activeCount":99},[],{"trials":1097,"activeCount":99},[],{"trials":1099,"activeCount":99},[],{"trials":1101,"activeCount":99},[],{"trials":1103,"activeCount":99},[1104,1115],{"nctId":1105,"briefTitle":1106,"status":1107,"phases":1108,"primaryCompletion":1109,"completion":1110,"start":1111,"enrollment":99,"conditions":1112,"interventions":1114},"NCT02009098","RCT of Postoperative Infections Following Caesarean Section Infections Following Caesarean Section","WITHDRAWN",[90],"2015-10","2016-06","2014-10",[1113],"Postoperative Infection",[1092],{"nctId":1116,"briefTitle":1117,"status":586,"phases":1118,"primaryCompletion":1119,"completion":1120,"start":1121,"enrollment":1122,"conditions":1123,"interventions":1127},"NCT02072798","Antibiotics and Gut Microbiota Among Newborn Infants",[90],"2014-07","2014-08","2014-02",42,[1124,1125,1126],"Surgical Wound Infection","Infection; Cesarean Section","Complications; Cesarean Section",[1092],{"trials":1129,"activeCount":99},[],{"intervention":1131,"totalTrials":363,"cells":1132},"Oxycodone",{"EARLY_PHASE1":1133,"PHASE1":1135,"PHASE2":1137,"PHASE3":1139,"PHASE4":1141,"NA":1162},{"trials":1134,"activeCount":99},[],{"trials":1136,"activeCount":99},[],{"trials":1138,"activeCount":99},[],{"trials":1140,"activeCount":99},[],{"trials":1142,"activeCount":99},[1143,1152],{"nctId":1144,"briefTitle":1145,"status":586,"phases":1146,"completion":1147,"start":1148,"enrollment":1149,"conditions":1150,"interventions":1151},"NCT00271973","OXY-2: The Pharmacogenetics of Oxycodone Analgesia in Human Experimental Pain Models",[90],"2007-01","2006-02",32,[541],[1131],{"nctId":1153,"briefTitle":1154,"status":586,"phases":1155,"primaryCompletion":1156,"completion":1156,"start":1157,"enrollment":1158,"conditions":1159,"interventions":1161},"NCT00260260","OXY-1: The Pharmacogenetics of Oxycodone Analgesia in Postoperative Pain",[90],"2007-12","2005-06",300,[1160],"Postoperative Pain",[1131],{"trials":1163,"activeCount":99},[],{"intervention":1165,"totalTrials":363,"cells":1166},"Metformin",{"EARLY_PHASE1":1167,"PHASE1":1169,"PHASE2":1171,"PHASE3":1173,"PHASE4":1175,"NA":1200},{"trials":1168,"activeCount":99},[],{"trials":1170,"activeCount":99},[],{"trials":1172,"activeCount":99},[],{"trials":1174,"activeCount":99},[],{"trials":1176,"activeCount":99},[1177,1188],{"nctId":1178,"briefTitle":1179,"status":586,"phases":1180,"primaryCompletion":1181,"completion":1182,"start":1183,"enrollment":1184,"conditions":1185,"interventions":1186},"NCT00451568","Metformin and Oral Contraceptives in PCOS",[90],"2012-01","2013-04","2007-03",90,[24],[1165,1187],"Desorelle",{"nctId":1189,"briefTitle":1190,"status":586,"phases":1191,"primaryCompletion":1192,"completion":1192,"start":1084,"enrollment":1193,"conditions":1194,"interventions":1196},"NCT00121966","South Danish Diabetes Study: Evaluation of the Antidiabetic Treatment of Type 2 Diabetes Mellitus",[90],"2007-07",400,[1195],"Type 2 Diabetes Mellitus",[1197,1198,1165,1199],"Insulin Aspart","Insulin NPH","Rosiglitazone",{"trials":1201,"activeCount":99},[],{"intervention":1203,"totalTrials":95,"cells":1204},"Doxycycline",{"EARLY_PHASE1":1205,"PHASE1":1207,"PHASE2":1209,"PHASE3":1211,"PHASE4":1213,"NA":1225},{"trials":1206,"activeCount":99},[],{"trials":1208,"activeCount":99},[],{"trials":1210,"activeCount":99},[],{"trials":1212,"activeCount":99},[],{"trials":1214,"activeCount":99},[1215],{"nctId":1216,"briefTitle":1217,"status":1107,"phases":1218,"primaryCompletion":1219,"completion":1033,"start":1220,"enrollment":1221,"conditions":1222,"interventions":1224},"NCT00952861","Antibiotics in Chronic Obstructive Pulmonary Disease (COPD)",[90],"2010-10","2009-10",140,[1223],"Pulmonary Disease, Chronic Obstructive",[1203],{"trials":1226,"activeCount":99},[],{"intervention":1228,"totalTrials":95,"cells":1229},"escitalopram",{"EARLY_PHASE1":1230,"PHASE1":1232,"PHASE2":1234,"PHASE3":1236,"PHASE4":1238,"NA":1248},{"trials":1231,"activeCount":99},[],{"trials":1233,"activeCount":99},[],{"trials":1235,"activeCount":99},[],{"trials":1237,"activeCount":99},[],{"trials":1239,"activeCount":99},[1240],{"nctId":1241,"briefTitle":1242,"status":586,"phases":1243,"completion":1244,"start":1083,"enrollment":516,"conditions":1245,"interventions":1247},"NCT00162968","Escitalopram as a Treatment for Pain in Polyneuropathy",[90],"2007-04",[21,1246],"Polyneuropathies",[1228],{"trials":1249,"activeCount":99},[],{"intervention":1251,"totalTrials":95,"cells":1252},"Spironolactone",{"EARLY_PHASE1":1253,"PHASE1":1255,"PHASE2":1257,"PHASE3":1259,"PHASE4":1261,"NA":1273},{"trials":1254,"activeCount":99},[],{"trials":1256,"activeCount":99},[],{"trials":1258,"activeCount":99},[],{"trials":1260,"activeCount":99},[],{"trials":1262,"activeCount":99},[1263],{"nctId":1264,"briefTitle":1265,"status":586,"phases":1266,"primaryCompletion":1267,"completion":1267,"start":1268,"enrollment":1269,"conditions":1270,"interventions":1272},"NCT01602861","The Effects of Spironolactone on Calcineurin Inhibitor Induced Nephrotoxicity",[90],"2021-04","2013-02",188,[1271],"Disorder Related to Renal Transplantation",[1251],{"trials":1274,"activeCount":99},[],{"intervention":1276,"totalTrials":95,"cells":1277},"Cipralex",{"EARLY_PHASE1":1278,"PHASE1":1280,"PHASE2":1282,"PHASE3":1284,"PHASE4":1286,"NA":1296},{"trials":1279,"activeCount":99},[],{"trials":1281,"activeCount":99},[],{"trials":1283,"activeCount":99},[],{"trials":1285,"activeCount":99},[],{"trials":1287,"activeCount":99},[1288],{"nctId":1289,"briefTitle":1290,"status":586,"phases":1291,"primaryCompletion":1292,"completion":1109,"start":1293,"enrollment":1122,"conditions":1294,"interventions":1295},"NCT01961180","The Effect of Cipralex on Quality of Life, Adrenal Activity Glucose Metabolism, Physical and Mental Health in PCOS",[90],"2015-07","2013-06",[24],[1276],{"trials":1297,"activeCount":99},[],{"intervention":1299,"totalTrials":95,"cells":1300},"Low-dose Rosuvastatin",{"EARLY_PHASE1":1301,"PHASE1":1303,"PHASE2":1305,"PHASE3":1307,"PHASE4":1309,"NA":1323},{"trials":1302,"activeCount":99},[],{"trials":1304,"activeCount":99},[],{"trials":1306,"activeCount":99},[],{"trials":1308,"activeCount":99},[],{"trials":1310,"activeCount":99},[1311],{"nctId":1312,"briefTitle":1313,"status":586,"phases":1314,"primaryCompletion":1315,"completion":1316,"start":1317,"enrollment":1318,"conditions":1319,"interventions":1321},"NCT01245894","Influence of Intensive Lipid Lowering Treatment Compared to Moderate Lipid Lowering Treatment",[90],"2009-06","2010-06","2007-11",87,[1320],"Myocardial Infarction [C14.907.585.500]",[1299,1322],"High-dose Rosuvastatin",{"trials":1324,"activeCount":99},[],{"intervention":1322,"totalTrials":95,"cells":1326},{"EARLY_PHASE1":1327,"PHASE1":1329,"PHASE2":1331,"PHASE3":1333,"PHASE4":1335,"NA":1341},{"trials":1328,"activeCount":99},[],{"trials":1330,"activeCount":99},[],{"trials":1332,"activeCount":99},[],{"trials":1334,"activeCount":99},[],{"trials":1336,"activeCount":99},[1337],{"nctId":1312,"briefTitle":1313,"status":586,"phases":1338,"primaryCompletion":1315,"completion":1316,"start":1317,"enrollment":1318,"conditions":1339,"interventions":1340},[90],[1320],[1299,1322],{"trials":1342,"activeCount":99},[],{"intervention":1344,"totalTrials":95,"cells":1345},"Lanreotide Autogel and Octreotide LAR",{"EARLY_PHASE1":1346,"PHASE1":1348,"PHASE2":1350,"PHASE3":1352,"PHASE4":1354,"NA":1364},{"trials":1347,"activeCount":99},[],{"trials":1349,"activeCount":99},[],{"trials":1351,"activeCount":99},[],{"trials":1353,"activeCount":99},[],{"trials":1355,"activeCount":99},[1356],{"nctId":1357,"briefTitle":1358,"status":586,"phases":1359,"completion":1083,"start":1360,"enrollment":16,"conditions":1361,"interventions":1363},"NCT00145405","Comparable Effects of Lanreotide Autogel and Octreotide LAR on GH, IGF-I Levels and Patient Satisfaction",[90],"2002-09",[1362],"Acromegaly",[1344],{"trials":1365,"activeCount":99},[],{"intervention":1367,"totalTrials":95,"cells":1368},"Calcipotriene + Betamethasone Dipropionate",{"EARLY_PHASE1":1369,"PHASE1":1371,"PHASE2":1373,"PHASE3":1375,"PHASE4":1377,"NA":1390},{"trials":1370,"activeCount":99},[],{"trials":1372,"activeCount":99},[],{"trials":1374,"activeCount":99},[],{"trials":1376,"activeCount":99},[],{"trials":1378,"activeCount":99},[1379],{"nctId":1380,"briefTitle":1381,"status":586,"phases":1382,"primaryCompletion":1383,"completion":1384,"start":1385,"enrollment":1386,"conditions":1387,"interventions":1389},"NCT02858713","Adherence in Topical Treatment of Psoriasis",[90],"2017-04-29","2017-08-29","2017-01-09",134,[1388],"Adherence",[1367],{"trials":1391,"activeCount":99},[],{"intervention":1393,"totalTrials":95,"cells":1394},"losartan",{"EARLY_PHASE1":1395,"PHASE1":1397,"PHASE2":1399,"PHASE3":1401,"PHASE4":1403,"NA":1415},{"trials":1396,"activeCount":99},[],{"trials":1398,"activeCount":99},[],{"trials":1400,"activeCount":99},[],{"trials":1402,"activeCount":99},[],{"trials":1404,"activeCount":99},[1405],{"nctId":1406,"briefTitle":1407,"status":416,"phases":1408,"completion":1409,"start":1410,"enrollment":878,"conditions":1411,"interventions":1414},"NCT00239096","Prevention of Decompensation in Liver Cirrhosis",[90],"2011-09","2005-09",[1412,1413],"Alcoholic Liver Cirrhosis","Ascites",[1393],{"trials":1416,"activeCount":99},[],{"intervention":1418,"totalTrials":95,"cells":1419},"Insulin NovoRapid versus Actrapid",{"EARLY_PHASE1":1420,"PHASE1":1422,"PHASE2":1424,"PHASE3":1426,"PHASE4":1428,"NA":1440},{"trials":1421,"activeCount":99},[],{"trials":1423,"activeCount":99},[],{"trials":1425,"activeCount":99},[],{"trials":1427,"activeCount":99},[],{"trials":1429,"activeCount":99},[1430],{"nctId":1431,"briefTitle":1432,"status":416,"phases":1433,"completion":1434,"start":1435,"enrollment":1436,"conditions":1437,"interventions":1439},"NCT00145353","Insulin NovoRapid Versus Actrapid in Treatment of Type 1 Diabetic Patients During Daily Adjustment of Insulin Dose",[90],"2006-06","2004-11",16,[1438],"Type 1 Diabetes Mellitus",[1418],{"trials":1441,"activeCount":99},[],{"intervention":1443,"totalTrials":95,"cells":1444},"Catapresan",{"EARLY_PHASE1":1445,"PHASE1":1447,"PHASE2":1449,"PHASE3":1451,"PHASE4":1453,"NA":1495},{"trials":1446,"activeCount":99},[],{"trials":1448,"activeCount":99},[],{"trials":1450,"activeCount":99},[],{"trials":1452,"activeCount":99},[],{"trials":1454,"activeCount":99},[1455],{"nctId":1456,"briefTitle":1457,"status":416,"phases":1458,"primaryCompletion":1459,"completion":1460,"start":1461,"enrollment":9,"conditions":1462,"interventions":1494},"NCT04564430","Clonidine for Tourniquet-related Pain in Children",[90],"2021-12-20","2022-01-01","2021-03-01",[1463,1464,1465,1466,1467,1468,1469,1470,1471,1472,1473,1474,1475,1476,1477,1478,1479,1480,1481,1482,1483,1484,1485,1486,1487,1488,1489,1490,1491,1492,1493],"Polydactyly Toe","Thumb Hypoplasia","Trigger Finger","Polydactyly; Fingers","Osteomyelitis of Hindfoot","Osteomyelitis of Midfoot","Congenital Talipes Equinovarus","Congenital Talipes Calcaneus","Tarsal Coalition","Club Foot","Clubfoot","Congenital Knee Deformity","Leg Length Inequality in Children","Flatfoot","Hollow Foot","Congenital Valgus Foot Deformity","Polydactylia","Polysyndactyly","Syndactyly","Thumb Aplasia","Congenital Hand and Foot Deformity","Subungual Exostosis","Finger Deformity","Toe Deformity","Osteomyelitis of the Foot","Calcaneus Deformity of Foot","Congenital Hand Deformity","Hand Deformities, Congenital","Valgus Foot Deformity","Toe Joint Deformity","Capsulitis of MTP Joint",[1443],{"trials":1496,"activeCount":99},[],{"intervention":1498,"totalTrials":95,"cells":1499},"azithromycin",{"EARLY_PHASE1":1500,"PHASE1":1502,"PHASE2":1504,"PHASE3":1506,"PHASE4":1508,"NA":1518},{"trials":1501,"activeCount":99},[],{"trials":1503,"activeCount":99},[],{"trials":1505,"activeCount":99},[],{"trials":1507,"activeCount":99},[],{"trials":1509,"activeCount":99},[1510],{"nctId":1511,"briefTitle":1512,"status":416,"phases":1513,"completion":1156,"start":1514,"enrollment":1515,"conditions":1516,"interventions":1517},"NCT00132860","Prophylactic Antibiotic Treatment of Patients With Chronic Obstructive Lung Disease (COLD)",[90],"2001-05",800,[1223],[1498],{"trials":1519,"activeCount":99},[],{"intervention":1521,"totalTrials":95,"cells":1522},"Rosuvastatin 5mg\u002Fday",{"EARLY_PHASE1":1523,"PHASE1":1525,"PHASE2":1527,"PHASE3":1529,"PHASE4":1531,"NA":1542},{"trials":1524,"activeCount":99},[],{"trials":1526,"activeCount":99},[],{"trials":1528,"activeCount":99},[],{"trials":1530,"activeCount":99},[],{"trials":1532,"activeCount":99},[1533],{"nctId":1534,"briefTitle":1535,"status":586,"phases":1536,"primaryCompletion":1315,"completion":1316,"start":1317,"enrollment":1318,"conditions":1537,"interventions":1540},"NCT01223625","Effect of Intensive Lipid Lowering Treatment Compared to Moderate Lipid Lowering Treatment on Endothelial Function",[90],[1538,1539],"Endothelial Dysfunction","Atherosclerosis",[1521,1541],"Rosuvastatin 40mg\u002Fday",{"trials":1543,"activeCount":99},[],{"intervention":1541,"totalTrials":95,"cells":1545},{"EARLY_PHASE1":1546,"PHASE1":1548,"PHASE2":1550,"PHASE3":1552,"PHASE4":1554,"NA":1560},{"trials":1547,"activeCount":99},[],{"trials":1549,"activeCount":99},[],{"trials":1551,"activeCount":99},[],{"trials":1553,"activeCount":99},[],{"trials":1555,"activeCount":99},[1556],{"nctId":1534,"briefTitle":1535,"status":586,"phases":1557,"primaryCompletion":1315,"completion":1316,"start":1317,"enrollment":1318,"conditions":1558,"interventions":1559},[90],[1538,1539],[1521,1541],{"trials":1561,"activeCount":99},[],{"intervention":1563,"totalTrials":95,"cells":1564},"Tablet Metformin 500 mg",{"EARLY_PHASE1":1565,"PHASE1":1567,"PHASE2":1569,"PHASE3":1571,"PHASE4":1573,"NA":1582},{"trials":1566,"activeCount":99},[],{"trials":1568,"activeCount":99},[],{"trials":1570,"activeCount":99},[],{"trials":1572,"activeCount":99},[],{"trials":1574,"activeCount":99},[1575],{"nctId":1576,"briefTitle":1577,"status":586,"phases":1578,"completion":1434,"start":1579,"enrollment":1122,"conditions":1580,"interventions":1581},"NCT00145379","The Effect of Metformin in Overweight Patients With Dysregulated Type 1 Diabetes Mellitus",[90],"2003-03",[1438],[1563],{"trials":1583,"activeCount":99},[],{"intervention":424,"totalTrials":95,"cells":1585},{"EARLY_PHASE1":1586,"PHASE1":1588,"PHASE2":1590,"PHASE3":1592,"PHASE4":1594,"NA":1600},{"trials":1587,"activeCount":99},[],{"trials":1589,"activeCount":99},[],{"trials":1591,"activeCount":99},[],{"trials":1593,"activeCount":99},[],{"trials":1595,"activeCount":99},[1596],{"nctId":414,"briefTitle":415,"status":416,"phases":1597,"primaryCompletion":418,"completion":418,"start":419,"enrollment":375,"conditions":1598,"interventions":1599},[90],[421,422],[424,425,426,427,428],{"trials":1601,"activeCount":99},[],{"intervention":425,"totalTrials":95,"cells":1603},{"EARLY_PHASE1":1604,"PHASE1":1606,"PHASE2":1608,"PHASE3":1610,"PHASE4":1612,"NA":1618},{"trials":1605,"activeCount":99},[],{"trials":1607,"activeCount":99},[],{"trials":1609,"activeCount":99},[],{"trials":1611,"activeCount":99},[],{"trials":1613,"activeCount":99},[1614],{"nctId":414,"briefTitle":415,"status":416,"phases":1615,"primaryCompletion":418,"completion":418,"start":419,"enrollment":375,"conditions":1616,"interventions":1617},[90],[421,422],[424,425,426,427,428],{"trials":1619,"activeCount":99},[],{"intervention":427,"totalTrials":95,"cells":1621},{"EARLY_PHASE1":1622,"PHASE1":1624,"PHASE2":1626,"PHASE3":1628,"PHASE4":1630,"NA":1636},{"trials":1623,"activeCount":99},[],{"trials":1625,"activeCount":99},[],{"trials":1627,"activeCount":99},[],{"trials":1629,"activeCount":99},[],{"trials":1631,"activeCount":99},[1632],{"nctId":414,"briefTitle":415,"status":416,"phases":1633,"primaryCompletion":418,"completion":418,"start":419,"enrollment":375,"conditions":1634,"interventions":1635},[90],[421,422],[424,425,426,427,428],{"trials":1637,"activeCount":99},[],{"intervention":428,"totalTrials":95,"cells":1639},{"EARLY_PHASE1":1640,"PHASE1":1642,"PHASE2":1644,"PHASE3":1646,"PHASE4":1648,"NA":1654},{"trials":1641,"activeCount":99},[],{"trials":1643,"activeCount":99},[],{"trials":1645,"activeCount":99},[],{"trials":1647,"activeCount":99},[],{"trials":1649,"activeCount":99},[1650],{"nctId":414,"briefTitle":415,"status":416,"phases":1651,"primaryCompletion":418,"completion":418,"start":419,"enrollment":375,"conditions":1652,"interventions":1653},[90],[421,422],[424,425,426,427,428],{"trials":1655,"activeCount":99},[],{"intervention":1187,"totalTrials":95,"cells":1657},{"EARLY_PHASE1":1658,"PHASE1":1660,"PHASE2":1662,"PHASE3":1664,"PHASE4":1666,"NA":1672},{"trials":1659,"activeCount":99},[],{"trials":1661,"activeCount":99},[],{"trials":1663,"activeCount":99},[],{"trials":1665,"activeCount":99},[],{"trials":1667,"activeCount":99},[1668],{"nctId":1178,"briefTitle":1179,"status":586,"phases":1669,"primaryCompletion":1181,"completion":1182,"start":1183,"enrollment":1184,"conditions":1670,"interventions":1671},[90],[24],[1165,1187],{"trials":1673,"activeCount":99},[],{"intervention":1675,"totalTrials":95,"cells":1676},"Phrenic nerve block with Ropivacaine",{"EARLY_PHASE1":1677,"PHASE1":1679,"PHASE2":1681,"PHASE3":1683,"PHASE4":1685,"NA":1696},{"trials":1678,"activeCount":99},[],{"trials":1680,"activeCount":99},[],{"trials":1682,"activeCount":99},[],{"trials":1684,"activeCount":99},[],{"trials":1686,"activeCount":99},[1687],{"nctId":1688,"briefTitle":1689,"status":586,"phases":1690,"primaryCompletion":1119,"completion":1119,"start":1691,"enrollment":1692,"conditions":1693,"interventions":1694},"NCT02173418","The Effect of Phrenic Nerve Blockade on Acute and Chronic Shoulder Pain in Patients for Lobectomy and Pneumonectomy",[90],"2012-11",76,[1160],[1675,1695],"Phrenic nerve block with saline",{"trials":1697,"activeCount":99},[],{"intervention":1695,"totalTrials":95,"cells":1699},{"EARLY_PHASE1":1700,"PHASE1":1702,"PHASE2":1704,"PHASE3":1706,"PHASE4":1708,"NA":1714},{"trials":1701,"activeCount":99},[],{"trials":1703,"activeCount":99},[],{"trials":1705,"activeCount":99},[],{"trials":1707,"activeCount":99},[],{"trials":1709,"activeCount":99},[1710],{"nctId":1688,"briefTitle":1689,"status":586,"phases":1711,"primaryCompletion":1119,"completion":1119,"start":1691,"enrollment":1692,"conditions":1712,"interventions":1713},[90],[1160],[1675,1695],{"trials":1715,"activeCount":99},[],{"intervention":1717,"totalTrials":95,"cells":1718},"pioglitazone",{"EARLY_PHASE1":1719,"PHASE1":1721,"PHASE2":1723,"PHASE3":1725,"PHASE4":1727,"NA":1736},{"trials":1720,"activeCount":99},[],{"trials":1722,"activeCount":99},[],{"trials":1724,"activeCount":99},[],{"trials":1726,"activeCount":99},[],{"trials":1728,"activeCount":99},[1729],{"nctId":1730,"briefTitle":1731,"status":586,"phases":1732,"primaryCompletion":1147,"completion":1147,"start":1360,"enrollment":1733,"conditions":1734,"interventions":1735},"NCT00145340","Pioglitazone Treatment in Polycystic Ovary Syndrome",[90],30,[24],[1717],{"trials":1737,"activeCount":99},[],{"intervention":1739,"totalTrials":95,"cells":1740},"Testim",{"EARLY_PHASE1":1741,"PHASE1":1743,"PHASE2":1745,"PHASE3":1747,"PHASE4":1749,"NA":1762},{"trials":1742,"activeCount":99},[],{"trials":1744,"activeCount":99},[],{"trials":1746,"activeCount":99},[],{"trials":1748,"activeCount":99},[],{"trials":1750,"activeCount":99},[1751],{"nctId":1752,"briefTitle":1753,"status":416,"phases":1754,"primaryCompletion":1755,"completion":1756,"start":1757,"enrollment":601,"conditions":1758,"interventions":1761},"NCT00700024","Odense Androgen Study - The Effect of Testim and Training in Hypogonadal Men",[90],"2010-01","2010-02","2008-04",[1759,1760],"Hypogonadism","Metabolic Syndrome",[1739],{"trials":1763,"activeCount":99},[],{"intervention":1765,"totalTrials":95,"cells":1766},"Bupivacaine in epidural catheter",{"EARLY_PHASE1":1767,"PHASE1":1769,"PHASE2":1771,"PHASE3":1773,"PHASE4":1775,"NA":1793},{"trials":1768,"activeCount":99},[],{"trials":1770,"activeCount":99},[],{"trials":1772,"activeCount":99},[],{"trials":1774,"activeCount":99},[],{"trials":1776,"activeCount":99},[1777],{"nctId":1778,"briefTitle":1779,"status":586,"phases":1780,"primaryCompletion":1781,"completion":1782,"start":1783,"enrollment":1784,"conditions":1785,"interventions":1788},"NCT02359175","Supplementary Epidural Analgesia in Video-Assisted Thoracic Surgery (VATS) - The SEAVATS Study",[90],"2019-01-24","2023-03-22","2015-02",161,[1786,21,1787],"Lung Neoplasms","Immune Suppression",[1765,1789,1790,1791,1792],"Fentanyl in epidural catheter","Oral Paracetamol","Oral NSAID","Oral opioids",{"trials":1794,"activeCount":99},[],{"intervention":1789,"totalTrials":95,"cells":1796},{"EARLY_PHASE1":1797,"PHASE1":1799,"PHASE2":1801,"PHASE3":1803,"PHASE4":1805,"NA":1811},{"trials":1798,"activeCount":99},[],{"trials":1800,"activeCount":99},[],{"trials":1802,"activeCount":99},[],{"trials":1804,"activeCount":99},[],{"trials":1806,"activeCount":99},[1807],{"nctId":1778,"briefTitle":1779,"status":586,"phases":1808,"primaryCompletion":1781,"completion":1782,"start":1783,"enrollment":1784,"conditions":1809,"interventions":1810},[90],[1786,21,1787],[1765,1789,1790,1791,1792],{"trials":1812,"activeCount":99},[],{"intervention":1790,"totalTrials":95,"cells":1814},{"EARLY_PHASE1":1815,"PHASE1":1817,"PHASE2":1819,"PHASE3":1821,"PHASE4":1823,"NA":1829},{"trials":1816,"activeCount":99},[],{"trials":1818,"activeCount":99},[],{"trials":1820,"activeCount":99},[],{"trials":1822,"activeCount":99},[],{"trials":1824,"activeCount":99},[1825],{"nctId":1778,"briefTitle":1779,"status":586,"phases":1826,"primaryCompletion":1781,"completion":1782,"start":1783,"enrollment":1784,"conditions":1827,"interventions":1828},[90],[1786,21,1787],[1765,1789,1790,1791,1792],{"trials":1830,"activeCount":99},[],{"intervention":1791,"totalTrials":95,"cells":1832},{"EARLY_PHASE1":1833,"PHASE1":1835,"PHASE2":1837,"PHASE3":1839,"PHASE4":1841,"NA":1847},{"trials":1834,"activeCount":99},[],{"trials":1836,"activeCount":99},[],{"trials":1838,"activeCount":99},[],{"trials":1840,"activeCount":99},[],{"trials":1842,"activeCount":99},[1843],{"nctId":1778,"briefTitle":1779,"status":586,"phases":1844,"primaryCompletion":1781,"completion":1782,"start":1783,"enrollment":1784,"conditions":1845,"interventions":1846},[90],[1786,21,1787],[1765,1789,1790,1791,1792],{"trials":1848,"activeCount":99},[],{"intervention":1792,"totalTrials":95,"cells":1850},{"EARLY_PHASE1":1851,"PHASE1":1853,"PHASE2":1855,"PHASE3":1857,"PHASE4":1859,"NA":1865},{"trials":1852,"activeCount":99},[],{"trials":1854,"activeCount":99},[],{"trials":1856,"activeCount":99},[],{"trials":1858,"activeCount":99},[],{"trials":1860,"activeCount":99},[1861],{"nctId":1778,"briefTitle":1779,"status":586,"phases":1862,"primaryCompletion":1781,"completion":1782,"start":1783,"enrollment":1784,"conditions":1863,"interventions":1864},[90],[1786,21,1787],[1765,1789,1790,1791,1792],{"trials":1866,"activeCount":99},[],{"intervention":1868,"totalTrials":95,"cells":1869},"Rosuvastatin",{"EARLY_PHASE1":1870,"PHASE1":1872,"PHASE2":1874,"PHASE3":1876,"PHASE4":1878,"NA":1888},{"trials":1871,"activeCount":99},[],{"trials":1873,"activeCount":99},[],{"trials":1875,"activeCount":99},[],{"trials":1877,"activeCount":99},[],{"trials":1879,"activeCount":99},[1880],{"nctId":1881,"briefTitle":1882,"status":586,"phases":1883,"completion":1315,"start":1317,"enrollment":1318,"conditions":1884,"interventions":1887},"NCT01203982","Effect of Intensive Lipid Lowering Treatment Compared to Moderate Lipid Lowering Treatment on Carotid Intima-media Thickness (CIMT)",[90],[1885,1886],"ST-segment Elevation Myocardial Infarction","Subclinical Carotid Atherosclerosis",[1868,1868],{"trials":1889,"activeCount":99},[],{"intervention":605,"totalTrials":95,"cells":1891},{"EARLY_PHASE1":1892,"PHASE1":1894,"PHASE2":1896,"PHASE3":1898,"PHASE4":1900,"NA":1906},{"trials":1893,"activeCount":99},[],{"trials":1895,"activeCount":99},[],{"trials":1897,"activeCount":99},[],{"trials":1899,"activeCount":99},[],{"trials":1901,"activeCount":99},[1902],{"nctId":596,"briefTitle":597,"status":586,"phases":1903,"primaryCompletion":599,"completion":599,"start":600,"enrollment":601,"conditions":1904,"interventions":1905},[90],[603],[605,560],{"trials":1907,"activeCount":99},[],{"intervention":1909,"totalTrials":95,"cells":1910},"carbamazepine oxcarbazepine",{"EARLY_PHASE1":1911,"PHASE1":1913,"PHASE2":1915,"PHASE3":1917,"PHASE4":1919,"NA":1929},{"trials":1912,"activeCount":99},[],{"trials":1914,"activeCount":99},[],{"trials":1916,"activeCount":99},[],{"trials":1918,"activeCount":99},[],{"trials":1920,"activeCount":99},[1921],{"nctId":1922,"briefTitle":1923,"status":586,"phases":1924,"primaryCompletion":1067,"completion":1067,"start":1925,"enrollment":19,"conditions":1926,"interventions":1928},"NCT00260247","Induction of Drug Metabolism: In Vivo Comparison of Carbamazepine and Oxcarbazepine.",[90],"2005-04",[1927],"Metabolic Clearance Rate",[1909],{"trials":1930,"activeCount":99},[],{"intervention":1197,"totalTrials":95,"cells":1932},{"EARLY_PHASE1":1933,"PHASE1":1935,"PHASE2":1937,"PHASE3":1939,"PHASE4":1941,"NA":1947},{"trials":1934,"activeCount":99},[],{"trials":1936,"activeCount":99},[],{"trials":1938,"activeCount":99},[],{"trials":1940,"activeCount":99},[],{"trials":1942,"activeCount":99},[1943],{"nctId":1189,"briefTitle":1190,"status":586,"phases":1944,"primaryCompletion":1192,"completion":1192,"start":1084,"enrollment":1193,"conditions":1945,"interventions":1946},[90],[1195],[1197,1198,1165,1199],{"trials":1948,"activeCount":99},[],{"intervention":1198,"totalTrials":95,"cells":1950},{"EARLY_PHASE1":1951,"PHASE1":1953,"PHASE2":1955,"PHASE3":1957,"PHASE4":1959,"NA":1965},{"trials":1952,"activeCount":99},[],{"trials":1954,"activeCount":99},[],{"trials":1956,"activeCount":99},[],{"trials":1958,"activeCount":99},[],{"trials":1960,"activeCount":99},[1961],{"nctId":1189,"briefTitle":1190,"status":586,"phases":1962,"primaryCompletion":1192,"completion":1192,"start":1084,"enrollment":1193,"conditions":1963,"interventions":1964},[90],[1195],[1197,1198,1165,1199],{"trials":1966,"activeCount":99},[],{"intervention":1199,"totalTrials":95,"cells":1968},{"EARLY_PHASE1":1969,"PHASE1":1971,"PHASE2":1973,"PHASE3":1975,"PHASE4":1977,"NA":1983},{"trials":1970,"activeCount":99},[],{"trials":1972,"activeCount":99},[],{"trials":1974,"activeCount":99},[],{"trials":1976,"activeCount":99},[],{"trials":1978,"activeCount":99},[1979],{"nctId":1189,"briefTitle":1190,"status":586,"phases":1980,"primaryCompletion":1192,"completion":1192,"start":1084,"enrollment":1193,"conditions":1981,"interventions":1982},[90],[1195],[1197,1198,1165,1199],{"trials":1984,"activeCount":99},[],{"intervention":1986,"totalTrials":95,"cells":1987},"Imipramine",{"EARLY_PHASE1":1988,"PHASE1":1990,"PHASE2":1992,"PHASE3":1994,"PHASE4":1996,"NA":2009},{"trials":1989,"activeCount":99},[],{"trials":1991,"activeCount":99},[],{"trials":1993,"activeCount":99},[],{"trials":1995,"activeCount":99},[],{"trials":1997,"activeCount":99},[1998],{"nctId":1999,"briefTitle":2000,"status":416,"phases":2001,"primaryCompletion":2002,"completion":2002,"start":1756,"enrollment":2003,"conditions":2004,"interventions":2006},"NCT01047488","Imipramine and Pregabalin Combination in Painful Polyneuropathy",[90],"2013-03",75,[2005],"Polyneuropathy",[1986,2007,2008],"Pregabalin","Imipramine, pregabalin",{"trials":2010,"activeCount":99},[],{"intervention":2007,"totalTrials":95,"cells":2012},{"EARLY_PHASE1":2013,"PHASE1":2015,"PHASE2":2017,"PHASE3":2019,"PHASE4":2021,"NA":2027},{"trials":2014,"activeCount":99},[],{"trials":2016,"activeCount":99},[],{"trials":2018,"activeCount":99},[],{"trials":2020,"activeCount":99},[],{"trials":2022,"activeCount":99},[2023],{"nctId":1999,"briefTitle":2000,"status":416,"phases":2024,"primaryCompletion":2002,"completion":2002,"start":1756,"enrollment":2003,"conditions":2025,"interventions":2026},[90],[2005],[1986,2007,2008],{"trials":2028,"activeCount":99},[],{"intervention":2008,"totalTrials":95,"cells":2030},{"EARLY_PHASE1":2031,"PHASE1":2033,"PHASE2":2035,"PHASE3":2037,"PHASE4":2039,"NA":2045},{"trials":2032,"activeCount":99},[],{"trials":2034,"activeCount":99},[],{"trials":2036,"activeCount":99},[],{"trials":2038,"activeCount":99},[],{"trials":2040,"activeCount":99},[2041],{"nctId":1999,"briefTitle":2000,"status":416,"phases":2042,"primaryCompletion":2002,"completion":2002,"start":1756,"enrollment":2003,"conditions":2043,"interventions":2044},[90],[2005],[1986,2007,2008],{"trials":2046,"activeCount":99},[],{"intervention":2048,"totalTrials":95,"cells":2049},"Escitalopram 20 mg",{"EARLY_PHASE1":2050,"PHASE1":2052,"PHASE2":2054,"PHASE3":2056,"PHASE4":2058,"NA":2068},{"trials":2051,"activeCount":99},[],{"trials":2053,"activeCount":99},[],{"trials":2055,"activeCount":99},[],{"trials":2057,"activeCount":99},[],{"trials":2059,"activeCount":99},[2060],{"nctId":2061,"briefTitle":2062,"status":586,"phases":2063,"primaryCompletion":2064,"completion":2064,"start":2065,"enrollment":620,"conditions":2066,"interventions":2067},"NCT05840692","The Effect of Escitalopram in PCOS",[90],"2017-10","2013-08",[24],[2048],{"trials":2069,"activeCount":99},[],{"intervention":2071,"totalTrials":95,"cells":2072},"esomeprazole",{"EARLY_PHASE1":2073,"PHASE1":2075,"PHASE2":2077,"PHASE3":2079,"PHASE4":2081,"NA":2092},{"trials":2074,"activeCount":99},[],{"trials":2076,"activeCount":99},[],{"trials":2078,"activeCount":99},[],{"trials":2080,"activeCount":99},[],{"trials":2082,"activeCount":99},[2083],{"nctId":2084,"briefTitle":2085,"status":586,"phases":2086,"primaryCompletion":1183,"completion":1183,"start":2087,"enrollment":2088,"conditions":2089,"interventions":2091},"NCT00120315","Proton Pump Inhibitor Treatment Stop",[90],"2003-12",171,[2090],"Dyspepsia",[2071],{"trials":2093,"activeCount":99},[],{"intervention":2095,"totalTrials":95,"cells":2096},"Ezetimibe",{"EARLY_PHASE1":2097,"PHASE1":2099,"PHASE2":2101,"PHASE3":2103,"PHASE4":2105,"NA":2117},{"trials":2098,"activeCount":99},[],{"trials":2100,"activeCount":99},[],{"trials":2102,"activeCount":99},[],{"trials":2104,"activeCount":99},[],{"trials":2106,"activeCount":99},[2107],{"nctId":2108,"briefTitle":2109,"status":586,"phases":2110,"primaryCompletion":2111,"completion":2112,"start":2113,"enrollment":1318,"conditions":2114,"interventions":2116},"NCT01385631","Ezetimibe In Addition To Atorvastatin Therapy On The Plaque Composition In Patients With Acute Myocardial Infarction.",[90],"2014-06","2014-09","2011-06",[2115],"ST-Segment Elevation Myocardial Infarction",[2095],{"trials":2118,"activeCount":99},[],{"intervention":2120,"totalTrials":95,"cells":2121},"Adalimumab",{"EARLY_PHASE1":2122,"PHASE1":2124,"PHASE2":2126,"PHASE3":2128,"PHASE4":2141,"NA":2143},{"trials":2123,"activeCount":99},[],{"trials":2125,"activeCount":99},[],{"trials":2127,"activeCount":99},[],{"trials":2129,"activeCount":99},[2130],{"nctId":2131,"briefTitle":2132,"status":586,"phases":2133,"primaryCompletion":2134,"completion":2135,"start":2136,"enrollment":2137,"conditions":2138,"interventions":2140},"NCT01670240","Adalimumab in the Treatment of Chronic Pouchitis",[89],"2015-09","2016-01","2012-08",13,[33,2139],"Pouchitis",[2120],{"trials":2142,"activeCount":99},[],{"trials":2144,"activeCount":99},[],{"intervention":2146,"totalTrials":95,"cells":2147},"Fluorouracil + folinic acid",{"EARLY_PHASE1":2148,"PHASE1":2150,"PHASE2":2152,"PHASE3":2154,"PHASE4":2166,"NA":2168},{"trials":2149,"activeCount":99},[],{"trials":2151,"activeCount":99},[],{"trials":2153,"activeCount":99},[],{"trials":2155,"activeCount":99},[2156],{"nctId":2157,"briefTitle":2158,"status":586,"phases":2159,"completion":2160,"start":2161,"enrollment":601,"conditions":2162,"interventions":2164},"NCT00212589","Patients Preference for Oral or i.v. Therapy",[89],"2004-04","2002-12",[2163],"Colorectal Cancer",[2165,2146],"Capecitabine",{"trials":2167,"activeCount":99},[],{"trials":2169,"activeCount":99},[],{"intervention":2171,"totalTrials":95,"cells":2172},"Candesartan",{"EARLY_PHASE1":2173,"PHASE1":2175,"PHASE2":2177,"PHASE3":2179,"PHASE4":2189,"NA":2191},{"trials":2174,"activeCount":99},[],{"trials":2176,"activeCount":99},[],{"trials":2178,"activeCount":99},[],{"trials":2180,"activeCount":99},[2181],{"nctId":2182,"briefTitle":2183,"status":416,"phases":2184,"primaryCompletion":1034,"completion":1315,"start":1148,"enrollment":1221,"conditions":2185,"interventions":2188},"NCT00294775","Effect of Angiotensin II Receptor Blockers (ARB) on Left Ventricular Reverse Remodelling After Aortic Valve Replacement in Severe Valvular Aortic Stenosis",[89],[2186,2187,214],"Aortic Valve Stenosis","Left Ventricular Hypertrophy",[2171],{"trials":2190,"activeCount":99},[],{"trials":2192,"activeCount":99},[],{"intervention":2194,"totalTrials":95,"cells":2195},"Fosaprepitant dimeglumine",{"EARLY_PHASE1":2196,"PHASE1":2198,"PHASE2":2200,"PHASE3":2202,"PHASE4":2216,"NA":2218},{"trials":2197,"activeCount":99},[],{"trials":2199,"activeCount":99},[],{"trials":2201,"activeCount":99},[],{"trials":2203,"activeCount":99},[2204],{"nctId":2205,"briefTitle":2206,"status":586,"phases":2207,"primaryCompletion":2208,"completion":2208,"start":2209,"enrollment":2210,"conditions":2211,"interventions":2215},"NCT01074697","Efficacy of Two Antiemetic Regimens in Patients Receiving Radiotherapy and Concomitant Weekly Cisplatin",[89],"2015-04","2010-04",246,[2212,2213,2214],"Nausea","Vomiting","Genital Neoplasms, Female",[2194],{"trials":2217,"activeCount":99},[],{"trials":2219,"activeCount":99},[],{"intervention":2221,"totalTrials":95,"cells":2222},"dronabinol",{"EARLY_PHASE1":2223,"PHASE1":2225,"PHASE2":2227,"PHASE3":2229,"PHASE4":2241,"NA":2243},{"trials":2224,"activeCount":99},[],{"trials":2226,"activeCount":99},[],{"trials":2228,"activeCount":99},[],{"trials":2230,"activeCount":99},[2231],{"nctId":2232,"briefTitle":2233,"status":586,"phases":2234,"primaryCompletion":2235,"completion":2235,"start":2236,"enrollment":2237,"conditions":2238,"interventions":2240},"NCT00760695","Cannabinoid Receptor (CB1) Agonist Treatment in Severe Chronic Anorexia Nervosa",[89],"2011-12","2008-10",24,[2239],"Anorexia Nervosa",[2221],{"trials":2242,"activeCount":99},[],{"trials":2244,"activeCount":99},[],{"intervention":2246,"totalTrials":95,"cells":2247},"Loperamide",{"EARLY_PHASE1":2248,"PHASE1":2250,"PHASE2":2252,"PHASE3":2254,"PHASE4":2266,"NA":2268},{"trials":2249,"activeCount":99},[],{"trials":2251,"activeCount":99},[],{"trials":2253,"activeCount":99},[],{"trials":2255,"activeCount":99},[2256],{"nctId":2257,"briefTitle":2258,"status":2259,"phases":2260,"primaryCompletion":2261,"completion":2261,"start":1111,"enrollment":16,"conditions":2262,"interventions":2265},"NCT02266849","Loperamide vs. Placebo's Effect on Ileostomy Output: A Clinical Randomized Blinded Cross-over Study","TERMINATED",[89],"2015-08",[2263,33,2264],"Rectal Cancer","Short Bowel Syndrome",[2246],{"trials":2267,"activeCount":99},[],{"trials":2269,"activeCount":99},[],{"intervention":2271,"totalTrials":95,"cells":2272},"Dexamethasone 24mg Solution for",{"EARLY_PHASE1":2273,"PHASE1":2275,"PHASE2":2277,"PHASE3":2279,"PHASE4":2294,"NA":2296},{"trials":2274,"activeCount":99},[],{"trials":2276,"activeCount":99},[],{"trials":2278,"activeCount":99},[],{"trials":2280,"activeCount":99},[2281],{"nctId":2282,"briefTitle":2283,"status":586,"phases":2284,"primaryCompletion":2285,"completion":2286,"start":2287,"enrollment":1184,"conditions":2288,"interventions":2292},"NCT03874936","The Effect of Perioperative Dexamethasone Administration on Postoperative Pain in Patients Undergoing Periacetabular Osteotomy.",[88,89],"2022-12-31","2023-12-31","2020-11-12",[2289,2290,1160,2291],"Dexamethasone","Hip Dysplasia","Postoperative Nausea and Vomiting",[2271,2293],"Saline Solution for",{"trials":2295,"activeCount":99},[],{"trials":2297,"activeCount":99},[],{"intervention":2293,"totalTrials":95,"cells":2299},{"EARLY_PHASE1":2300,"PHASE1":2302,"PHASE2":2304,"PHASE3":2306,"PHASE4":2312,"NA":2314},{"trials":2301,"activeCount":99},[],{"trials":2303,"activeCount":99},[],{"trials":2305,"activeCount":99},[],{"trials":2307,"activeCount":99},[2308],{"nctId":2282,"briefTitle":2283,"status":586,"phases":2309,"primaryCompletion":2285,"completion":2286,"start":2287,"enrollment":1184,"conditions":2310,"interventions":2311},[88,89],[2289,2290,1160,2291],[2271,2293],{"trials":2313,"activeCount":99},[],{"trials":2315,"activeCount":99},[],{"intervention":2317,"totalTrials":95,"cells":2318},"Melatonin 10 MG",{"EARLY_PHASE1":2319,"PHASE1":2321,"PHASE2":2323,"PHASE3":2325,"PHASE4":2339,"NA":2341},{"trials":2320,"activeCount":99},[],{"trials":2322,"activeCount":99},[],{"trials":2324,"activeCount":99},[],{"trials":2326,"activeCount":99},[2327],{"nctId":2328,"briefTitle":2329,"status":586,"phases":2330,"primaryCompletion":2331,"completion":2332,"start":2333,"enrollment":2334,"conditions":2335,"interventions":2338},"NCT06476392","Melatonin fOr CHronic bAck Pain (The MOCHA Trial)",[89],"2026-03-28","2026-04-13","2024-12-11",220,[2336,2337],"Back Pain Lower Back Chronic","Insomnia",[2317],{"trials":2340,"activeCount":99},[],{"trials":2342,"activeCount":99},[],{"intervention":2344,"totalTrials":95,"cells":2345},"Cholecalciferol",{"EARLY_PHASE1":2346,"PHASE1":2348,"PHASE2":2350,"PHASE3":2352,"PHASE4":2365,"NA":2367},{"trials":2347,"activeCount":99},[],{"trials":2349,"activeCount":99},[],{"trials":2351,"activeCount":99},[],{"trials":2353,"activeCount":99},[2354],{"nctId":2355,"briefTitle":2356,"status":586,"phases":2357,"primaryCompletion":2358,"completion":588,"start":2359,"enrollment":2360,"conditions":2361,"interventions":2364},"NCT00968877","Vitamin D and Chronic Renal Insufficiency",[89],"2009-12","2009-09",56,[2362,2363],"Vitamin D Deficiency","Chronic Renal Insufficiency",[2344],{"trials":2366,"activeCount":99},[],{"trials":2368,"activeCount":99},[],{"intervention":2370,"totalTrials":95,"cells":2371},"Stem cell",{"EARLY_PHASE1":2372,"PHASE1":2374,"PHASE2":2376,"PHASE3":2386,"PHASE4":2388,"NA":2390},{"trials":2373,"activeCount":99},[],{"trials":2375,"activeCount":99},[],{"trials":2377,"activeCount":99},[2378],{"nctId":2379,"briefTitle":2380,"status":586,"phases":2381,"primaryCompletion":2382,"completion":2382,"start":2383,"enrollment":408,"conditions":2384,"interventions":2385},"NCT03776721","Treatment of Breast Cancer-related Lymphedema With Stem Cells and Fat Grafting",[88],"2021-06-01","2018-12-18",[31],[2370],{"trials":2387,"activeCount":99},[],{"trials":2389,"activeCount":99},[],{"trials":2391,"activeCount":99},[],{"intervention":1073,"totalTrials":95,"cells":2393},{"EARLY_PHASE1":2394,"PHASE1":2396,"PHASE2":2398,"PHASE3":2404,"PHASE4":2406,"NA":2408},{"trials":2395,"activeCount":99},[],{"trials":2397,"activeCount":99},[],{"trials":2399,"activeCount":99},[2400],{"nctId":1064,"briefTitle":1065,"status":586,"phases":2401,"completion":1067,"start":1068,"enrollment":9,"conditions":2402,"interventions":2403},[87,88],[1070,1071],[1055,1073,1074],{"trials":2405,"activeCount":99},[],{"trials":2407,"activeCount":99},[],{"trials":2409,"activeCount":99},[],{"intervention":1074,"totalTrials":95,"cells":2411},{"EARLY_PHASE1":2412,"PHASE1":2414,"PHASE2":2416,"PHASE3":2422,"PHASE4":2424,"NA":2426},{"trials":2413,"activeCount":99},[],{"trials":2415,"activeCount":99},[],{"trials":2417,"activeCount":99},[2418],{"nctId":1064,"briefTitle":1065,"status":586,"phases":2419,"completion":1067,"start":1068,"enrollment":9,"conditions":2420,"interventions":2421},[87,88],[1070,1071],[1055,1073,1074],{"trials":2423,"activeCount":99},[],{"trials":2425,"activeCount":99},[],{"trials":2427,"activeCount":99},[],{"intervention":2429,"totalTrials":95,"cells":2430},"Navelbine",{"EARLY_PHASE1":2431,"PHASE1":2433,"PHASE2":2435,"PHASE3":2447,"PHASE4":2449,"NA":2451},{"trials":2432,"activeCount":99},[],{"trials":2434,"activeCount":99},[],{"trials":2436,"activeCount":99},[2437],{"nctId":2438,"briefTitle":2439,"status":586,"phases":2440,"primaryCompletion":2441,"completion":2441,"start":2442,"enrollment":2443,"conditions":2444,"interventions":2446},"NCT00887783","Navelbine And Radiotherapy in Locally Advanced Lung Cancer",[88],"2016-09-01","2009-05-01",117,[2445],"Non-small Cell Lung Cancer",[2429],{"trials":2448,"activeCount":99},[],{"trials":2450,"activeCount":99},[],{"trials":2452,"activeCount":99},[],{"intervention":2454,"totalTrials":95,"cells":2455},"Recombinant human thyrotropin",{"EARLY_PHASE1":2456,"PHASE1":2458,"PHASE2":2460,"PHASE3":2473,"PHASE4":2475,"NA":2477},{"trials":2457,"activeCount":99},[],{"trials":2459,"activeCount":99},[],{"trials":2461,"activeCount":99},[2462],{"nctId":2463,"briefTitle":2464,"status":586,"phases":2465,"completion":2466,"start":2467,"enrollment":2468,"conditions":2469,"interventions":2472},"NCT00145366","rhTSH, Thyroid Size, and Radioiodine Therapy in Benign Goiter",[88],"2005-07","2002-04",110,[2470,2471],"Benign Nontoxic and Toxic Goiter","Graves' Disease",[2454],{"trials":2474,"activeCount":99},[],{"trials":2476,"activeCount":99},[],{"trials":2478,"activeCount":99},[],{"intervention":2480,"totalTrials":95,"cells":2481},"Protopic 0.1 % Topical Ointment",{"EARLY_PHASE1":2482,"PHASE1":2484,"PHASE2":2486,"PHASE3":2497,"PHASE4":2499,"NA":2501},{"trials":2483,"activeCount":99},[],{"trials":2485,"activeCount":99},[],{"trials":2487,"activeCount":99},[2488],{"nctId":2489,"briefTitle":2490,"status":586,"phases":2491,"primaryCompletion":2492,"completion":2492,"start":2493,"enrollment":9,"conditions":2494,"interventions":2496},"NCT04541290","Tacrolimus as Treatment of Breast Cancer-Related Lymphedema",[87,88],"2022-01-06","2020-09-22",[2495],"Breast Cancer Lymphedema",[2480],{"trials":2498,"activeCount":99},[],{"trials":2500,"activeCount":99},[],{"trials":2502,"activeCount":99},[],{"intervention":2504,"totalTrials":95,"cells":2505},"Tacrolimus ointment",{"EARLY_PHASE1":2506,"PHASE1":2508,"PHASE2":2510,"PHASE3":2520,"PHASE4":2522,"NA":2524},{"trials":2507,"activeCount":99},[],{"trials":2509,"activeCount":99},[],{"trials":2511,"activeCount":99},[2512],{"nctId":2513,"briefTitle":2514,"status":416,"phases":2515,"primaryCompletion":2516,"completion":2516,"start":2517,"enrollment":601,"conditions":2518,"interventions":2519},"NCT04390685","Prevention of Breast Cancer-related Lymphedma With Tacrolimus",[87,88],"2022-09","2020-02-26",[31],[2504],{"trials":2521,"activeCount":99},[],{"trials":2523,"activeCount":99},[],{"trials":2525,"activeCount":99},[],{"intervention":2527,"totalTrials":95,"cells":2528},"Naltrexone Pill",{"EARLY_PHASE1":2529,"PHASE1":2531,"PHASE2":2533,"PHASE3":2545,"PHASE4":2547,"NA":2549},{"trials":2530,"activeCount":99},[],{"trials":2532,"activeCount":99},[],{"trials":2534,"activeCount":99},[2535],{"nctId":2536,"briefTitle":2537,"status":586,"phases":2538,"primaryCompletion":2539,"completion":2539,"start":2540,"enrollment":2541,"conditions":2542,"interventions":2544},"NCT04270877","Fibromyalgia and Naltrexone: The FINAL Study",[88],"2022-12-27","2021-01-06",99,[2543],"Fibromyalgia",[2527],{"trials":2546,"activeCount":99},[],{"trials":2548,"activeCount":99},[],{"trials":2550,"activeCount":99},[],{"intervention":2552,"totalTrials":95,"cells":2553},"BM41",{"EARLY_PHASE1":2554,"PHASE1":2556,"PHASE2":2570,"PHASE3":2572,"PHASE4":2574,"NA":2576},{"trials":2555,"activeCount":99},[],{"trials":2557,"activeCount":99},[2558],{"nctId":2559,"briefTitle":2560,"status":586,"phases":2561,"primaryCompletion":2562,"completion":2562,"start":2563,"enrollment":2564,"conditions":2565,"interventions":2568},"NCT04912076","S.C. Immunotherapy With BM41 in Patients With Allergic Rhino-conjunctivitis Caused by Birch Pollen",[87],"2019-03-22","2018-09-17",47,[2566,2567],"Birch Pollen Allergy","Allergic Rhinoconjunctivitis",[2552,2569],"ALK Alutard SQ Betula verrucosa",{"trials":2571,"activeCount":99},[],{"trials":2573,"activeCount":99},[],{"trials":2575,"activeCount":99},[],{"trials":2577,"activeCount":99},[],{"intervention":2569,"totalTrials":95,"cells":2579},{"EARLY_PHASE1":2580,"PHASE1":2582,"PHASE2":2588,"PHASE3":2590,"PHASE4":2592,"NA":2594},{"trials":2581,"activeCount":99},[],{"trials":2583,"activeCount":99},[2584],{"nctId":2559,"briefTitle":2560,"status":586,"phases":2585,"primaryCompletion":2562,"completion":2562,"start":2563,"enrollment":2564,"conditions":2586,"interventions":2587},[87],[2566,2567],[2552,2569],{"trials":2589,"activeCount":99},[],{"trials":2591,"activeCount":99},[],{"trials":2593,"activeCount":99},[],{"trials":2595,"activeCount":99},[],{"intervention":2597,"totalTrials":95,"cells":2598},"PITAC",{"EARLY_PHASE1":2599,"PHASE1":2601,"PHASE2":2617,"PHASE3":2619,"PHASE4":2621,"NA":2623},{"trials":2600,"activeCount":99},[],{"trials":2602,"activeCount":99},[2603],{"nctId":2604,"briefTitle":2605,"status":416,"phases":2606,"primaryCompletion":2607,"completion":2607,"start":2608,"enrollment":9,"conditions":2609,"interventions":2616},"NCT06421610","OPC5: Pressurized IntraThoracic Aerosol Chemotherapy (PITAC) in Patients With Malignant Pleural Effusion.",[87],"2024-12-31","2023-09-15",[2610,2611,15,2612,2613,2614,2615],"Malignant Pleural Effusion","Pleural Neoplasms","Chemotherapy Effect","Chemotherapeutic Toxicity","Pleural Carcinomatosis","Pleural Cavity Effusion",[2597],{"trials":2618,"activeCount":99},[],{"trials":2620,"activeCount":99},[],{"trials":2622,"activeCount":99},[],{"trials":2624,"activeCount":99},[],{"intervention":2626,"totalTrials":95,"cells":2627},"Epidural",{"EARLY_PHASE1":2628,"PHASE1":2641,"PHASE2":2643,"PHASE3":2645,"PHASE4":2647,"NA":2649},{"trials":2629,"activeCount":99},[2630],{"nctId":2631,"briefTitle":2632,"status":416,"phases":2633,"primaryCompletion":2634,"completion":2635,"start":2636,"enrollment":1158,"conditions":2637,"interventions":2640},"NCT02866305","Study Designed to Optimize the Treatment of Primary Pneumothorax",[86],"2017-12","2024-12","2009-03",[2638,2639],"Primary Spontaneous Pneumothorax","Pleural Disease",[2626],{"trials":2642,"activeCount":99},[],{"trials":2644,"activeCount":99},[],{"trials":2646,"activeCount":99},[],{"trials":2648,"activeCount":99},[],{"trials":2650,"activeCount":99},[],{"intervention":2165,"totalTrials":561,"cells":2652},{"EARLY_PHASE1":2653,"PHASE1":2655,"PHASE2":2657,"PHASE3":2659,"PHASE4":2675,"NA":2677},{"trials":2654,"activeCount":99},[],{"trials":2656,"activeCount":99},[],{"trials":2658,"activeCount":99},[],{"trials":2660,"activeCount":99},[2661,2665],{"nctId":2157,"briefTitle":2158,"status":586,"phases":2662,"completion":2160,"start":2161,"enrollment":601,"conditions":2663,"interventions":2664},[89],[2163],[2165,2146],{"nctId":2666,"briefTitle":2667,"status":586,"phases":2668,"primaryCompletion":2236,"completion":2236,"start":2669,"enrollment":2670,"conditions":2671,"interventions":2673},"NCT00212615","XELOX III. Xeloda in Combination With Eloxatin for Patients With Advanced or Metastatic Colorectal Cancer",[88,89],"2004-02",116,[2672],"C04.588.274.476.411.307",[2674,2165],"Oxaliplatin",{"trials":2676,"activeCount":99},[],{"trials":2678,"activeCount":99},[2679],{"nctId":2680,"briefTitle":2681,"status":586,"phases":2682,"primaryCompletion":2683,"completion":2684,"start":2685,"enrollment":2686,"conditions":2687,"interventions":2689},"NCT01295086","Taxotere®, Eloxatin® and Xeloda® (TEX) in Combination With Herceptin® as Treatment for HER2 Positive Non-resectable Cancer",[91],"2014-11","2018-01","2011-03",27,[2688],"Adenocarcinoma",[2690,2674,2165,2691],"Docetaxel","Trastuzumab",{"intervention":2693,"totalTrials":561,"cells":2694},"levetiracetam",{"EARLY_PHASE1":2695,"PHASE1":2697,"PHASE2":2699,"PHASE3":2701,"PHASE4":2703,"NA":2721},{"trials":2696,"activeCount":99},[],{"trials":2698,"activeCount":99},[],{"trials":2700,"activeCount":99},[],{"trials":2702,"activeCount":99},[],{"trials":2704,"activeCount":99},[2705,2712],{"nctId":2706,"briefTitle":2707,"status":586,"phases":2708,"primaryCompletion":1034,"completion":1034,"start":1147,"enrollment":1733,"conditions":2709,"interventions":2711},"NCT00423527","Levetiracetam in Central Pain in Multiple Sclerosis(MS)",[90],[2710],"Multiple Sclerosis",[2693],{"nctId":2713,"briefTitle":2714,"status":586,"phases":2715,"primaryCompletion":2716,"completion":2236,"start":2717,"enrollment":620,"conditions":2718,"interventions":2720},"NCT00286260","Levetiracetam for Painful Polyneuropathy",[90],"2008-08","2006-01",[2719],"Painful Polyneuropathy",[2693],{"trials":2722,"activeCount":99},[2723],{"nctId":2724,"briefTitle":2725,"status":586,"phases":2726,"completion":2727,"start":2728,"enrollment":2729,"conditions":2730,"interventions":2731},"NCT00262262","The Effect of Levetiracetam on the Postmastectomy Pain Syndrome",[91],"2006-09","2004-03",25,[1160],[2732],"Levetiracetam",{"intervention":2734,"totalTrials":363,"cells":2735},"Adipose-Derived Regenerative Cells",{"EARLY_PHASE1":2736,"PHASE1":2738,"PHASE2":2740,"PHASE3":2752,"PHASE4":2754,"NA":2756},{"trials":2737,"activeCount":99},[],{"trials":2739,"activeCount":99},[],{"trials":2741,"activeCount":99},[2742],{"nctId":2743,"briefTitle":2744,"status":586,"phases":2745,"primaryCompletion":2746,"completion":2746,"start":2747,"enrollment":1035,"conditions":2748,"interventions":2751},"NCT07355530","Can Adipose Derived Regenrative Cells be Used for Treating Erectile Dysfunction After Radical Prostatectomy",[88],"2021-03-03","2018-01-20",[2749,2750],"ED","Adipose Derived Stem Cells",[2734],{"trials":2753,"activeCount":99},[],{"trials":2755,"activeCount":99},[],{"trials":2757,"activeCount":99},[2758],{"nctId":2759,"briefTitle":2760,"status":416,"phases":2761,"primaryCompletion":2762,"completion":2762,"start":2763,"enrollment":1733,"conditions":2764,"interventions":2766},"NCT02987101","Treatment of Chronic Leg Ulcers With Autologous Stromal Vascular Fraction",[91],"2018-06","2016-11",[2765],"Leg Ulcer",[2734],{"intervention":2674,"totalTrials":363,"cells":2768},{"EARLY_PHASE1":2769,"PHASE1":2771,"PHASE2":2773,"PHASE3":2775,"PHASE4":2781,"NA":2783},{"trials":2770,"activeCount":99},[],{"trials":2772,"activeCount":99},[],{"trials":2774,"activeCount":99},[],{"trials":2776,"activeCount":99},[2777],{"nctId":2666,"briefTitle":2667,"status":586,"phases":2778,"primaryCompletion":2236,"completion":2236,"start":2669,"enrollment":2670,"conditions":2779,"interventions":2780},[88,89],[2672],[2674,2165],{"trials":2782,"activeCount":99},[],{"trials":2784,"activeCount":99},[2785],{"nctId":2680,"briefTitle":2681,"status":586,"phases":2786,"primaryCompletion":2683,"completion":2684,"start":2685,"enrollment":2686,"conditions":2787,"interventions":2788},[91],[2688],[2690,2674,2165,2691],{"intervention":2790,"totalTrials":95,"cells":2791},"Penicillin V + metronidazol",{"EARLY_PHASE1":2792,"PHASE1":2794,"PHASE2":2796,"PHASE3":2798,"PHASE4":2800,"NA":2802},{"trials":2793,"activeCount":99},[],{"trials":2795,"activeCount":99},[],{"trials":2797,"activeCount":99},[],{"trials":2799,"activeCount":99},[],{"trials":2801,"activeCount":99},[],{"trials":2803,"activeCount":99},[2804],{"nctId":2805,"briefTitle":2806,"status":416,"phases":2807,"primaryCompletion":2808,"completion":2809,"start":2810,"enrollment":2811,"conditions":2812,"interventions":2814},"NCT03326661","Peritonsillar Abscess: Aspiration Versus Tonsillectomy a Chaud",[91],"2019-11-30","2020-11-30","2017-11-10",128,[2813],"Peritonsillar Abscess",[2790],{"intervention":2816,"totalTrials":95,"cells":2817},"Antibiotics",{"EARLY_PHASE1":2818,"PHASE1":2820,"PHASE2":2822,"PHASE3":2824,"PHASE4":2826,"NA":2828},{"trials":2819,"activeCount":99},[],{"trials":2821,"activeCount":99},[],{"trials":2823,"activeCount":99},[],{"trials":2825,"activeCount":99},[],{"trials":2827,"activeCount":99},[],{"trials":2829,"activeCount":99},[2830],{"nctId":2831,"briefTitle":2832,"status":586,"phases":2833,"primaryCompletion":2834,"completion":2834,"start":2835,"enrollment":2443,"conditions":2836,"interventions":2838},"NCT03919851","Physician Administered Antibiotics in a Prehospital Setting",[],"2019-02-15","2018-10-31",[2837],"Sepsis",[2816],{"intervention":2840,"totalTrials":95,"cells":2841},"Aflibercept Injection [Eylea]",{"EARLY_PHASE1":2842,"PHASE1":2844,"PHASE2":2846,"PHASE3":2848,"PHASE4":2850,"NA":2852},{"trials":2843,"activeCount":99},[],{"trials":2845,"activeCount":99},[],{"trials":2847,"activeCount":99},[],{"trials":2849,"activeCount":99},[],{"trials":2851,"activeCount":99},[],{"trials":2853,"activeCount":99},[2854],{"nctId":2855,"briefTitle":2856,"status":586,"phases":2857,"primaryCompletion":2858,"completion":2858,"start":2859,"enrollment":2564,"conditions":2860,"interventions":2863},"NCT03651011","Navigated Laser In Branch Retinal Vein Occlusion Study",[91],"2021-10-05","2018-08-10",[2861,2862],"Branch Retinal Vein Occlusion","Macular Edema",[2840],{"intervention":2865,"totalTrials":95,"cells":2866},"Measure endometrial markers",{"EARLY_PHASE1":2867,"PHASE1":2869,"PHASE2":2871,"PHASE3":2873,"PHASE4":2875,"NA":2877},{"trials":2868,"activeCount":99},[],{"trials":2870,"activeCount":99},[],{"trials":2872,"activeCount":99},[],{"trials":2874,"activeCount":99},[],{"trials":2876,"activeCount":99},[],{"trials":2878,"activeCount":99},[2879],{"nctId":2880,"briefTitle":2881,"status":416,"phases":2882,"primaryCompletion":2883,"completion":2286,"start":2884,"enrollment":2885,"conditions":2886,"interventions":2890},"NCT03843034","Endometrial Markers in Autoimmune Diseases",[],"2023-01-31","2019-02-18",22,[2887,2888,2889],"Endometrial Receptivity","Fertility","Autoimmune Diseases",[2865],{"intervention":2892,"totalTrials":95,"cells":2893},"IV. PPI",{"EARLY_PHASE1":2894,"PHASE1":2896,"PHASE2":2898,"PHASE3":2900,"PHASE4":2902,"NA":2904},{"trials":2895,"activeCount":99},[],{"trials":2897,"activeCount":99},[],{"trials":2899,"activeCount":99},[],{"trials":2901,"activeCount":99},[],{"trials":2903,"activeCount":99},[],{"trials":2905,"activeCount":99},[2906],{"nctId":2907,"briefTitle":2908,"status":416,"phases":2909,"primaryCompletion":2910,"completion":2911,"start":2912,"enrollment":2913,"conditions":2914,"interventions":2916},"NCT02434978","Doppler-guided Endoscopic Treatment in Peptic Ulcer Bleeding",[91],"2017-09","2018-03","2014-01",125,[2915],"Peptic Ulcer Bleeding",[2892],{"intervention":2918,"totalTrials":95,"cells":2919},"Fecal microbiota transplantation",{"EARLY_PHASE1":2920,"PHASE1":2922,"PHASE2":2924,"PHASE3":2926,"PHASE4":2928,"NA":2930},{"trials":2921,"activeCount":99},[],{"trials":2923,"activeCount":99},[],{"trials":2925,"activeCount":99},[],{"trials":2927,"activeCount":99},[],{"trials":2929,"activeCount":99},[],{"trials":2931,"activeCount":99},[2932],{"nctId":2933,"briefTitle":2934,"status":586,"phases":2935,"primaryCompletion":2936,"completion":2936,"start":2937,"enrollment":2938,"conditions":2939,"interventions":2940},"NCT03058900","Efficacy and Safety of Fecal Microbiota Transplantation in Peripheral Psoriatic Arthritis",[91],"2020-06-02","2017-05-16",31,[712],[2918,2941],"Methotrexate",{"intervention":2941,"totalTrials":95,"cells":2943},{"EARLY_PHASE1":2944,"PHASE1":2946,"PHASE2":2948,"PHASE3":2950,"PHASE4":2952,"NA":2954},{"trials":2945,"activeCount":99},[],{"trials":2947,"activeCount":99},[],{"trials":2949,"activeCount":99},[],{"trials":2951,"activeCount":99},[],{"trials":2953,"activeCount":99},[],{"trials":2955,"activeCount":99},[2956],{"nctId":2933,"briefTitle":2934,"status":586,"phases":2957,"primaryCompletion":2936,"completion":2936,"start":2937,"enrollment":2938,"conditions":2958,"interventions":2959},[91],[712],[2918,2941],{"intervention":2961,"totalTrials":95,"cells":2962},"Pradaxa",{"EARLY_PHASE1":2963,"PHASE1":2965,"PHASE2":2967,"PHASE3":2969,"PHASE4":2971,"NA":2973},{"trials":2964,"activeCount":99},[],{"trials":2966,"activeCount":99},[],{"trials":2968,"activeCount":99},[],{"trials":2970,"activeCount":99},[],{"trials":2972,"activeCount":99},[],{"trials":2974,"activeCount":99},[2975],{"nctId":2976,"briefTitle":2977,"status":586,"phases":2978,"primaryCompletion":1783,"completion":1783,"start":2979,"enrollment":2980,"conditions":2981,"interventions":2982},"NCT01593150","Early Versus Late DC-cardioversion of Persistent Atrial Fibrillation. Effect on Atrial Remodeling,Inflammatory and Neurohumoral Markers and Recurrence of Atrial Fibrillation",[91],"2011-11",141,[214],[2961],{"intervention":2984,"totalTrials":95,"cells":2985},"antihypertensive drugs according to current guidelines",{"EARLY_PHASE1":2986,"PHASE1":2988,"PHASE2":2990,"PHASE3":2992,"PHASE4":2994,"NA":2996},{"trials":2987,"activeCount":99},[],{"trials":2989,"activeCount":99},[],{"trials":2991,"activeCount":99},[],{"trials":2993,"activeCount":99},[],{"trials":2995,"activeCount":99},[],{"trials":2997,"activeCount":99},[2998],{"nctId":2999,"briefTitle":3000,"status":586,"phases":3001,"completion":3002,"start":3003,"enrollment":3004,"conditions":3005,"interventions":3007},"NCT00225030","Observational Study of the Prognosis in Treated Arterial Hypertension",[],"2004-07","1970-01",1000,[3006],"Hypertension",[2984],{"intervention":3009,"totalTrials":95,"cells":3010},"Acetylcysteine",{"EARLY_PHASE1":3011,"PHASE1":3013,"PHASE2":3015,"PHASE3":3017,"PHASE4":3019,"NA":3021},{"trials":3012,"activeCount":99},[],{"trials":3014,"activeCount":99},[],{"trials":3016,"activeCount":99},[],{"trials":3018,"activeCount":99},[],{"trials":3020,"activeCount":99},[],{"trials":3022,"activeCount":99},[3023],{"nctId":3024,"briefTitle":3025,"status":586,"phases":3026,"primaryCompletion":2002,"completion":2002,"start":2209,"enrollment":3027,"conditions":3028,"interventions":3030},"NCT01160627","Prevention of Contrast-induced Nephropathy in Patients With Acute Myocardial Infarction",[91],720,[3029],"Contrast Induced Nephropathy",[3009,3031,3032],"Sodium bicarbonate","Combined Acetylcystein and Sodium Bicarbonate",{"intervention":3031,"totalTrials":95,"cells":3034},{"EARLY_PHASE1":3035,"PHASE1":3037,"PHASE2":3039,"PHASE3":3041,"PHASE4":3043,"NA":3045},{"trials":3036,"activeCount":99},[],{"trials":3038,"activeCount":99},[],{"trials":3040,"activeCount":99},[],{"trials":3042,"activeCount":99},[],{"trials":3044,"activeCount":99},[],{"trials":3046,"activeCount":99},[3047],{"nctId":3024,"briefTitle":3025,"status":586,"phases":3048,"primaryCompletion":2002,"completion":2002,"start":2209,"enrollment":3027,"conditions":3049,"interventions":3050},[91],[3029],[3009,3031,3032],{"intervention":3032,"totalTrials":95,"cells":3052},{"EARLY_PHASE1":3053,"PHASE1":3055,"PHASE2":3057,"PHASE3":3059,"PHASE4":3061,"NA":3063},{"trials":3054,"activeCount":99},[],{"trials":3056,"activeCount":99},[],{"trials":3058,"activeCount":99},[],{"trials":3060,"activeCount":99},[],{"trials":3062,"activeCount":99},[],{"trials":3064,"activeCount":99},[3065],{"nctId":3024,"briefTitle":3025,"status":586,"phases":3066,"primaryCompletion":2002,"completion":2002,"start":2209,"enrollment":3027,"conditions":3067,"interventions":3068},[91],[3029],[3009,3031,3032],{"intervention":3070,"totalTrials":95,"cells":3071},"dandelion juice",{"EARLY_PHASE1":3072,"PHASE1":3074,"PHASE2":3076,"PHASE3":3078,"PHASE4":3080,"NA":3082},{"trials":3073,"activeCount":99},[],{"trials":3075,"activeCount":99},[],{"trials":3077,"activeCount":99},[],{"trials":3079,"activeCount":99},[],{"trials":3081,"activeCount":99},[],{"trials":3083,"activeCount":99},[3084],{"nctId":3085,"briefTitle":3086,"status":586,"phases":3087,"primaryCompletion":3088,"completion":3088,"start":1033,"enrollment":3089,"conditions":3090,"interventions":3093},"NCT00442091","Dandelion Juice in the Treatment of Dyshidrotic Hand Eczema",[91],"2019-12",4,[3091,3092],"Vesicular Palmoplantar Eczema","Pompholyx",[3070],{"intervention":3095,"totalTrials":95,"cells":3096},"Antibiotic",{"EARLY_PHASE1":3097,"PHASE1":3099,"PHASE2":3101,"PHASE3":3103,"PHASE4":3105,"NA":3107},{"trials":3098,"activeCount":99},[],{"trials":3100,"activeCount":99},[],{"trials":3102,"activeCount":99},[],{"trials":3104,"activeCount":99},[],{"trials":3106,"activeCount":99},[],{"trials":3108,"activeCount":99},[3109],{"nctId":3110,"briefTitle":3111,"status":416,"phases":3112,"primaryCompletion":3113,"completion":3114,"start":3115,"enrollment":3116,"conditions":3117,"interventions":3118},"NCT06177444","Post-operative Antibiotics; Effects on Risk of Infection After Cochlear Implant Surgery",[],"2024-07-30","2024-08-01","2023-09-01",920,[1113],[3095],{"intervention":3120,"totalTrials":95,"cells":3121},"teriparatide",{"EARLY_PHASE1":3122,"PHASE1":3124,"PHASE2":3126,"PHASE3":3128,"PHASE4":3130,"NA":3132},{"trials":3123,"activeCount":99},[],{"trials":3125,"activeCount":99},[],{"trials":3127,"activeCount":99},[],{"trials":3129,"activeCount":99},[],{"trials":3131,"activeCount":99},[],{"trials":3133,"activeCount":99},[3134],{"nctId":3135,"briefTitle":3136,"status":586,"phases":3137,"primaryCompletion":3138,"completion":3139,"start":3140,"enrollment":3141,"conditions":3142,"interventions":3144},"NCT02563353","PTH and Vibration in OSteoporosis Study",[91],"2018-11","2019-11","2015-11",35,[3143],"Osteoporosis",[3120],{"intervention":2690,"totalTrials":95,"cells":3146},{"EARLY_PHASE1":3147,"PHASE1":3149,"PHASE2":3151,"PHASE3":3153,"PHASE4":3155,"NA":3157},{"trials":3148,"activeCount":99},[],{"trials":3150,"activeCount":99},[],{"trials":3152,"activeCount":99},[],{"trials":3154,"activeCount":99},[],{"trials":3156,"activeCount":99},[],{"trials":3158,"activeCount":99},[3159],{"nctId":2680,"briefTitle":2681,"status":586,"phases":3160,"primaryCompletion":2683,"completion":2684,"start":2685,"enrollment":2686,"conditions":3161,"interventions":3162},[91],[2688],[2690,2674,2165,2691],{"intervention":2691,"totalTrials":95,"cells":3164},{"EARLY_PHASE1":3165,"PHASE1":3167,"PHASE2":3169,"PHASE3":3171,"PHASE4":3173,"NA":3175},{"trials":3166,"activeCount":99},[],{"trials":3168,"activeCount":99},[],{"trials":3170,"activeCount":99},[],{"trials":3172,"activeCount":99},[],{"trials":3174,"activeCount":99},[],{"trials":3176,"activeCount":99},[3177],{"nctId":2680,"briefTitle":2681,"status":586,"phases":3178,"primaryCompletion":2683,"completion":2684,"start":2685,"enrollment":2686,"conditions":3179,"interventions":3180},[91],[2688],[2690,2674,2165,2691],{"intervention":3182,"totalTrials":95,"cells":3183},"Rosuvastatin 5mg",{"EARLY_PHASE1":3184,"PHASE1":3186,"PHASE2":3188,"PHASE3":3190,"PHASE4":3192,"NA":3194},{"trials":3185,"activeCount":99},[],{"trials":3187,"activeCount":99},[],{"trials":3189,"activeCount":99},[],{"trials":3191,"activeCount":99},[],{"trials":3193,"activeCount":99},[],{"trials":3195,"activeCount":99},[3196],{"nctId":3197,"briefTitle":3198,"status":586,"phases":3199,"primaryCompletion":1315,"completion":1315,"start":1317,"enrollment":1318,"conditions":3200,"interventions":3201},"NCT01058915","Influence of Intensive Lipid Lowering Treatment Compared to Moderate Lipid Lowering Treatment on Plaque Composition in Patients With ST-Segment Elevation Myocardial Infarction (MI)",[91],[148],[3182,3202],"Rosuvastatin 40mg",{"intervention":3202,"totalTrials":95,"cells":3204},{"EARLY_PHASE1":3205,"PHASE1":3207,"PHASE2":3209,"PHASE3":3211,"PHASE4":3213,"NA":3215},{"trials":3206,"activeCount":99},[],{"trials":3208,"activeCount":99},[],{"trials":3210,"activeCount":99},[],{"trials":3212,"activeCount":99},[],{"trials":3214,"activeCount":99},[],{"trials":3216,"activeCount":99},[3217],{"nctId":3197,"briefTitle":3198,"status":586,"phases":3218,"primaryCompletion":1315,"completion":1315,"start":1317,"enrollment":1318,"conditions":3219,"interventions":3220},[91],[148],[3182,3202],{"intervention":3222,"totalTrials":95,"cells":3223},"Synovial biopsy",{"EARLY_PHASE1":3224,"PHASE1":3226,"PHASE2":3228,"PHASE3":3230,"PHASE4":3232,"NA":3234},{"trials":3225,"activeCount":99},[],{"trials":3227,"activeCount":99},[],{"trials":3229,"activeCount":99},[],{"trials":3231,"activeCount":99},[],{"trials":3233,"activeCount":99},[],{"trials":3235,"activeCount":99},[3236],{"nctId":3237,"briefTitle":3238,"status":586,"phases":3239,"primaryCompletion":3240,"completion":3240,"start":3241,"enrollment":601,"conditions":3242,"interventions":3243},"NCT02652299","Fibrocytes in Early and Longstanding Rheumatoid Arthritis",[],"2018-04-04","2016-03",[710],[3222],{"intervention":3245,"totalTrials":95,"cells":3246},"Perindopril",{"EARLY_PHASE1":3247,"PHASE1":3249,"PHASE2":3251,"PHASE3":3253,"PHASE4":3255,"NA":3257},{"trials":3248,"activeCount":99},[],{"trials":3250,"activeCount":99},[],{"trials":3252,"activeCount":99},[],{"trials":3254,"activeCount":99},[],{"trials":3256,"activeCount":99},[],{"trials":3258,"activeCount":99},[3259],{"nctId":3260,"briefTitle":3261,"status":2259,"phases":3262,"primaryCompletion":3263,"completion":3264,"start":3265,"enrollment":2564,"conditions":3266,"interventions":3268},"NCT00915928","Chronic Subdural Hematoma - Reduction of Recurrence by Treatment With Angiotensin Converting Enzyme Inhibitors",[91],"2012-05","2012-06","2009-07",[3267],"Hematoma, Subdural, Chronic",[3245]]